Document and Entity Information
Document and Entity Information Document - shares | 3 Months Ended | |
Mar. 31, 2017 | Apr. 21, 2017 | |
Entity Information [Line Items] | ||
Entity Registrant Name | BORGWARNER INC. | |
Entity Central Index Key | 908,255 | |
Document Type | 10-Q | |
Document Period End Date | Mar. 31, 2017 | |
Amendment Flag | false | |
Document Fiscal Year Focus | 2,017 | |
Document Fiscal Period Focus | Q1 | |
Current Fiscal Year End Date | --12-31 | |
Entity Well-known Seasoned Issuer | Yes | |
Entity Voluntary Filers | No | |
Entity Current Reporting Status | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Common Stock, Shares Outstanding | 212,219,590 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions | Mar. 31, 2017 | Dec. 31, 2016 |
ASSETS | ||
Cash | $ 358.4 | $ 443.7 |
Receivables, net | 1,934.3 | 1,689.3 |
Inventories, net | 656.9 | 641.2 |
Prepayments and other current assets | 157.7 | 137.4 |
Total current assets | 3,107.3 | 2,911.6 |
Property, plant and equipment, net | 2,553.1 | 2,501.8 |
Investments and other long-term receivables | 530 | 502.2 |
Goodwill | 1,708.1 | 1,702.2 |
Other intangible assets, net | 455.7 | 463.5 |
Other non-current assets | 729.5 | 753.4 |
Total assets | 9,083.7 | 8,834.7 |
LIABILITIES AND EQUITY | ||
Notes payable and other short-term debt | 255.1 | 175.9 |
Accounts payable and accrued expenses | 1,841.3 | 1,847.3 |
Income taxes payable | 54.8 | 68.6 |
Total current liabilities | 2,151.2 | 2,091.8 |
Long-term debt | 2,040.3 | 2,043.6 |
Other non-current liabilities: | ||
Liability for Asbestos and Environmental Claims, Gross | 813.8 | 827.6 |
Retirement-related liabilities | 292 | 294.1 |
Other | 306.7 | 275.7 |
Total other non-current liabilities | 1,412.5 | 1,397.4 |
Common stock | 2.5 | 2.5 |
Capital in excess of par value | 1,077.6 | 1,104.3 |
Retained earnings | 4,374.7 | 4,215.2 |
Accumulated other comprehensive loss | (674.2) | (722.1) |
Common stock held in treasury | (1,377.2) | (1,381.6) |
Total BorgWarner Inc. stockholders’ equity | 3,403.4 | 3,218.3 |
Noncontrolling interest | 76.3 | 83.6 |
Total equity | 3,479.7 | 3,301.9 |
Total liabilities and equity | $ 9,083.7 | $ 8,834.7 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Income Statement [Abstract] | ||
Net sales | $ 2,407 | $ 2,268.6 |
Cost of sales | 1,889.7 | 1,804.3 |
Gross profit | 517.3 | 464.3 |
Selling, general and administrative expenses | 218.8 | 188.4 |
Other expense, net | 5.8 | 11.7 |
Operating income | 292.7 | 264.2 |
Equity in affiliates’ earnings, net of tax | (9.7) | (9.1) |
Interest income | (1.5) | (1.6) |
Interest expense and finance charges | 18 | 21.3 |
Earnings before income taxes and noncontrolling interest | 285.9 | 253.6 |
Provision for income taxes | 86.3 | 80.4 |
Net earnings | 199.6 | 173.2 |
Net earnings attributable to the noncontrolling interest, net of tax | 10.4 | 9.1 |
Net earnings attributable to BorgWarner Inc. | $ 189.2 | $ 164.1 |
Earnings per share — basic | $ 0.89 | $ 0.75 |
Earnings per share — diluted | $ 0.89 | $ 0.75 |
Weighted average shares outstanding (thousands): | ||
Basic | 211,596 | 217,388 |
Diluted | 212,236 | 218,137 |
Dividends declared per share | $ 0.14 | $ 0.13 |
Condensed Consolidated Stateme4
Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Millions | 3 Months Ended | ||
Mar. 31, 2017 | Mar. 31, 2016 | ||
Statement of Comprehensive Income [Abstract] | |||
Net earnings attributable to BorgWarner Inc. | $ 189.2 | $ 164.1 | |
Other comprehensive income (loss) | |||
Foreign currency translation adjustments | 49 | 68.4 | |
Hedge instruments | [1] | (1.2) | 1.7 |
Defined benefit postretirement plans | [1] | 0.1 | (0.2) |
Other | [1] | 0 | (0.5) |
Total other comprehensive income attributable to BorgWarner Inc. | 47.9 | 69.4 | |
Comprehensive income attributable to BorgWarner Inc. | 237.1 | 233.5 | |
Comprehensive income attributable to the noncontrolling interest | 4 | 1.6 | |
Comprehensive income | $ 241.1 | $ 235.1 | |
[1] | Net of income taxes. |
Condensed Consolidated Stateme5
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
OPERATING | ||
Net earnings | $ 199.6 | $ 173.2 |
Adjustments to reconcile net earnings to net cash flows from operations: | ||
Depreciation and amortization | 97.3 | 94.4 |
Restructuring expense, net of cash paid | 0 | 0.1 |
Stock-based compensation expense | 13.1 | 9.6 |
Deferred income tax provision | 20.6 | 23.9 |
Equity in affiliates’ earnings, net of dividends received, and other | (9.5) | (15.7) |
Net earnings adjusted for non-cash charges to operations | 321.1 | 285.5 |
Changes in assets and liabilities: | ||
Receivables | (215.4) | (155.8) |
Inventories | (5.5) | (17.9) |
Prepayments and other current assets | (8.7) | 0.5 |
Accounts payable and accrued expenses | (16.3) | (43.6) |
Income taxes payable | (16.5) | (25.8) |
Other non-current assets and liabilities | 1.6 | (8.5) |
Net cash provided by operating activities | 60.3 | 34.4 |
INVESTING | ||
Capital expenditures, including tooling outlays | (130.9) | (104.3) |
Proceeds from asset disposals and other | 0.3 | (1.1) |
Payment for venture capital investment | (1.5) | 0 |
Net cash used in investing activities | (132.7) | (103.2) |
FINANCING | ||
Net increase in notes payable | 74.4 | 19.7 |
Repayments of long-term debt, including current portion | (6.4) | (8.7) |
Payments for purchase of treasury stock | (31) | (79.5) |
Payments for stock-based compensation items | (1.3) | (7.6) |
Dividends paid to BorgWarner stockholders | (29.7) | (28.2) |
Dividends paid to noncontrolling stockholders | (21.8) | (20.5) |
Net cash used in financing activities | (15.8) | (124.8) |
Effect of exchange rate changes on cash | 2.9 | 8.2 |
Net decrease in cash | (85.3) | (185.4) |
Cash at beginning of year | 443.7 | 577.7 |
Cash at end of period | 358.4 | 392.3 |
Cash paid during the period for: | ||
Interest | 31.9 | 29.3 |
Income taxes, net of refunds | $ 78.5 | $ 84.4 |
Basis of Presentation
Basis of Presentation | 3 Months Ended |
Mar. 31, 2017 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements of BorgWarner Inc. and Consolidated Subsidiaries (the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes necessary for a comprehensive presentation of financial position, results of operations and cash flow activity required by GAAP for complete financial statements. In the opinion of management, all normal recurring adjustments necessary for a fair statement of results have been included. Operating results for the three months ended March 31, 2017 are not necessarily indicative of the results that may be expected for the year ending December 31, 2017. The balance sheet as of December 31, 2016 was derived from the audited financial statements as of that date. For further information, refer to the Consolidated Financial Statements and Footnotes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2016. Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and accompanying notes, as well as, the amounts of revenues and expenses reported during the periods covered by those financial statements and accompanying notes. Actual results could differ from these estimates. Certain prior period amounts have been reclassified to conform to current period presentation. |
Research and Development Expend
Research and Development Expenditures | 3 Months Ended |
Mar. 31, 2017 | |
Research and Development [Abstract] | |
Research and Development Expenditures | Research and Development Expenditures The Company's net Research & Development ("R&D") expenditures are included in selling, general and administrative expenses of the Condensed Consolidated Statements of Operations. Customer reimbursements are netted against gross R&D expenditures as they are considered a recovery of cost. Customer reimbursements for prototypes are recorded net of prototype costs based on customer contracts, typically either when the prototype is shipped or when it is accepted by the customer. Customer reimbursements for engineering services are recorded when performance obligations are satisfied in accordance with the contract and accepted by the customer. Financial risks and rewards transfer upon shipment, acceptance of a prototype component by the customer or upon completion of the performance obligation as stated in the respective customer agreement. The following table presents the Company’s gross and net expenditures on R&D activities: Three Months Ended March 31, (in millions) 2017 2016 Gross R&D expenditures $ 112.0 $ 100.6 Customer reimbursements (15.6 ) (15.3 ) Net R&D expenditures $ 96.4 $ 85.3 The Company has contracts with several customers at the Company's various R&D locations. No such contract exceeded 5% of annual net R&D expenditures in any of the periods presented. |
Other Expense, Net
Other Expense, Net | 3 Months Ended |
Mar. 31, 2017 | |
Other Income and Expenses [Abstract] | |
Other Expense, net | Other Expense, net Items included in other expense, net consist of: Three Months Ended March 31, (in millions) 2017 2016 Lease termination settlement $ 5.3 $ — Merger and acquisition expense — 5.8 Restructuring expense — 6.4 Other expense (income) 0.5 (0.5 ) Other expense, net $ 5.8 $ 11.7 During the first quarter of 2017, the Company recorded a loss of $5.3 million related to the termination of a long term property lease for a manufacturing facility located in Europe. During the first quarter of 2016, the Company incurred transition and realignment expenses and other professional fees of $5.8 million associated with the November 2015 acquisition of Remy International, Inc. ("Remy"). During the first quarter of 2016, the Company recorded restructuring expense of $6.4 million . This expense related to Drivetrain and Engine segment actions designed to improve future profitability and competitiveness. See the Restructuring footnote to the Condensed Consolidated Financial Statements for further discussion of these expenses. |
Income Taxes
Income Taxes | 3 Months Ended |
Mar. 31, 2017 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The Company's provision for income taxes is based upon an estimated annual tax rate for the year applied to federal, state and foreign income. On a quarterly basis, the annual effective tax rate is adjusted, as appropriate, based upon changed facts and circumstances, if any, as compared to those forecasted at the beginning of the fiscal year and each interim period thereafter. At March 31, 2017, the Company's effective tax rate for the first quarter was 30.2% . This rate includes tax expense of $3.4 million related to one-time tax adjustments. At March 31, 2016, the Company's effective tax rate for the first quarter was 31.7% . This rate includes tax benefits of $1.0 million related to restructuring expense as discussed in the Other Expense, net footnote to the Condensed Consolidated Financial Statements, and $1.0 million related to other one-time tax adjustments. The annual effective tax rates differ from the U.S. statutory rate primarily due to foreign rates which differ from those in the U.S., the realization of certain business tax credits, including foreign tax credits, and favorable permanent differences between book and tax treatment for certain items, including equity in affiliates' earnings. |
Inventories, net
Inventories, net | 3 Months Ended |
Mar. 31, 2017 | |
Inventory Disclosure [Abstract] | |
Inventories, net | Inventories, net Certain U.S. inventories are measured by the last-in, first-out (“LIFO”) method at the lower of cost or market, while other U.S. and foreign operations use the first-in, first-out (“FIFO”) or average-cost methods at the lower of cost and net realizable value. Inventories consisted of the following: March 31, December 31, (in millions) 2017 2016 Raw material and supplies $ 387.6 $ 378.6 Work in progress 111.9 102.9 Finished goods 171.8 174.9 FIFO inventories 671.3 656.4 LIFO reserve (14.4 ) (15.2 ) Inventories, net $ 656.9 $ 641.2 |
Property, Plant and Equipment,
Property, Plant and Equipment, net | 3 Months Ended |
Mar. 31, 2017 | |
Property, Plant and Equipment [Abstract] | |
Property, Plant and Equipment, net | Property, Plant and Equipment, net March 31, December 31, (in millions) 2017 2016 Land, land use rights and buildings $ 807.3 $ 781.6 Machinery and equipment 2,472.5 2,371.2 Capital leases 3.0 3.9 Construction in progress 366.7 338.2 Total property, plant and equipment, gross 3,649.5 3,494.9 Less: accumulated depreciation (1,236.7 ) (1,137.5 ) Property, plant and equipment, net, excluding tooling 2,412.8 2,357.4 Tooling, net of amortization 140.3 144.4 Property, plant and equipment, net $ 2,553.1 $ 2,501.8 As of March 31, 2017 and December 31, 2016, accounts payable of $62.8 million and $85.3 million , respectively, were related to property, plant and equipment purchases. Interest costs capitalized for the three months ended March 31, 2017 and 2016 were $4.3 million and $3.7 million , respectively. |
Product Warranty
Product Warranty | 3 Months Ended |
Mar. 31, 2017 | |
Product Warranties Disclosures [Abstract] | |
Product Warranty | Product Warranty The Company provides warranties on some, but not all, of its products. The warranty terms are typically from one to three years. Provisions for estimated expenses related to product warranty are made at the time products are sold. These estimates are established using historical information about the nature, frequency and average cost of warranty claim settlements as well as product manufacturing and industry developments and recoveries from third parties. Management actively studies trends of warranty claims and takes action to improve product quality and minimize warranty claims. Management believes that the warranty accrual is appropriate; however, actual claims incurred could differ from the original estimates, requiring adjustments to the accrual. The following table summarizes the activity in the product warranty accrual accounts: (in millions) 2017 2016 Beginning balance, January 1 $ 95.3 $ 107.9 Provisions 27.6 24.6 Payments (15.3 ) (19.0 ) Translation adjustment 1.4 2.9 Ending balance, March 31 $ 109.0 $ 116.4 The product warranty liability is classified in the Condensed Consolidated Balance Sheets as follows: March 31, December 31, (in millions) 2017 2016 Accounts payable and accrued expenses $ 65.0 $ 63.9 Other non-current liabilities 44.0 31.4 Total product warranty liability $ 109.0 $ 95.3 |
Notes Payable and Long-Term Deb
Notes Payable and Long-Term Debt | 3 Months Ended |
Mar. 31, 2017 | |
Debt Disclosure [Abstract] | |
Notes Payable and Long-Term Debt | Notes Payable and Long-Term Debt As of March 31, 2017 and December 31, 2016, the Company had short-term and long-term debt outstanding as follows: March 31, December 31, (in millions) 2017 2016 Short-term debt Short-term borrowings $ 231.7 $ 156.5 Long-term debt 8.00% Senior notes due 10/01/19 ($134 million par value) 138.7 139.1 4.625% Senior notes due 09/15/20 ($250 million par value) 251.8 251.9 1.80% Senior notes due 11/7/22 (€500 million par value) 527.7 520.7 3.375% Senior notes due 03/15/25 ($500 million par value) 495.7 495.6 7.125% Senior notes due 02/15/29 ($121 million par value) 118.8 118.8 4.375% Senior notes due 03/15/45 ($500 million par value) 493.4 493.3 Term loan facilities and other 37.6 43.6 Total long-term debt 2,063.7 2,063.0 Less: current portion 23.4 19.4 Long-term debt, net of current portion $ 2,040.3 $ 2,043.6 In July 2016, the Company terminated interest rate swaps which had the effect of converting $384.0 million of fixed rate notes to variable rates. The gain on the termination is being amortized into interest expense over the remaining terms of the notes. The value related to these swap terminations as of March 31, 2017 was $3.7 million and $1.2 million on the 4.625% and 8.00% notes, respectively, as an increase to the notes. The value of these interest rate swaps as of December 31, 2016 was $3.9 million and $1.3 million on the 4.625% and 8.00% notes, respectively, as an increase to the notes. The Company terminated fixed to floating interest rate swaps in 2009. The gain on the termination is being amortized into interest expense over the remaining term of the notes. The value related to these swap terminations at March 31, 2017 and December 31, 2016 was $3.8 million and $4.1 million , respectively, on the 8.00% note as an increase to the note. The weighted average interest rate on short-term borrowings outstanding as of March 31, 2017 and December 31, 2016 was 2.1% and 2.3% , respectively. The weighted average interest rate on all borrowings outstanding, including the effects of outstanding swaps, as of March 31, 2017 and December 31, 2016 was 3.8% . The Company has a $1 billion multi-currency revolving credit facility which includes a feature that allows the Company's borrowings to be increased to $1.25 billion . The facility provides for borrowings through June 30, 2019. The Company has one key financial covenant as part of the credit agreement which is a debt to EBITDA ("Earnings Before Interest, Taxes, Depreciation and Amortization") ratio. The Company was in compliance with the financial covenant at March 31, 2017 and expects to remain compliant in future periods. At March 31, 2017 and December 31, 2016, the Company had no outstanding borrowings under this facility. The Company's commercial paper program allows the Company to issue short-term, unsecured commercial paper notes up to a maximum aggregate principal amount outstanding of $1 billion . Under this program, the Company may issue notes from time to time and will use the proceeds for general corporate purposes. At March 31, 2017 and December 31, 2016, the Company had outstanding borrowings of $160.0 million and $50.8 million , respectively, under this program, which is classified in the Condensed Consolidated Balance Sheets in Notes payable and other short-term debt. The total current combined borrowing capacity under the multi-currency revolving credit facility and commercial paper program cannot exceed $1 billion . As of March 31, 2017 and December 31, 2016, the estimated fair values of the Company’s senior unsecured notes totaled $2,104.8 million and $2,081.4 million , respectively. The estimated fair values were $78.7 million and $62.0 million higher than their carrying value at March 31, 2017 and December 31, 2016, respectively. Fair market values of the senior unsecured notes are developed using observable values for similar debt instruments, which are considered Level 2 inputs as defined by ASC Topic 820. The carrying values of the Company's multi-currency revolving credit facility and commercial paper program approximates fair value. The fair value estimates do not necessarily reflect the values the Company could realize in the current markets. The Company had outstanding letters of credit of $23.7 million and $32.3 million at March 31, 2017 and December 31, 2016, respectively. The letters of credit typically act as guarantees of payment to certain third parties in accordance with specified terms and conditions. |
Fair Value Measurements
Fair Value Measurements | 3 Months Ended |
Mar. 31, 2017 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Fair Value Measurements ASC Topic 820 emphasizes that fair value is a market-based measurement, not an entity specific measurement. Therefore, a fair value measurement should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering market participant assumptions in fair value measurements, ASC Topic 820 establishes a fair value hierarchy, which prioritizes the inputs used in measuring fair values as follows: Level 1: Observable inputs such as quoted prices for identical assets or liabilities in active markets; Level 2: Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. Assets and liabilities measured at fair value are based on one or more of the following three valuation techniques noted in ASC Topic 820: A. Market approach: Prices and other relevant information generated by market transactions involving identical or comparable assets, liabilities or a group of assets or liabilities, such as a business. B. Cost approach: Amount that would be required to replace the service capacity of an asset (replacement cost). C. Income approach: Techniques to convert future amounts to a single present amount based upon market expectations (including present value techniques, option-pricing and excess earnings models). The following tables classify assets and liabilities measured at fair value on a recurring basis as of March 31, 2017 and December 31, 2016: Basis of fair value measurements (in millions) Balance at March 31, 2017 Quoted prices in active markets for identical items (Level 1) Significant other observable inputs (Level 2) Significant unobservable inputs (Level 3) Valuation technique Assets: Commodity contracts $ 0.2 $ — $ 0.2 $ — A Foreign currency contracts $ 6.2 $ — $ 6.2 $ — A Other long-term receivables (insurance settlement agreement note receivable) $ 72.2 $ — $ 72.2 $ — C Liabilities: Foreign currency contracts $ 2.3 $ — $ 2.3 $ — A Basis of fair value measurements (in millions) Balance at December 31, 2016 Quoted prices in active markets for identical items (Level 1) Significant other observable inputs (Level 2) Significant unobservable inputs (Level 3) Valuation technique Assets: Commodity contracts $ 0.1 $ — $ 0.1 $ — A Foreign currency contracts $ 7.2 $ — $ 7.2 $ — A Other long-term receivables (insurance settlement agreement note receivable) $ 71.5 $ — $ 71.5 $ — C Liabilities: Foreign currency contracts $ 1.1 $ — $ 1.1 $ — A |
Financial Instruments
Financial Instruments | 3 Months Ended |
Mar. 31, 2017 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Financial Instruments | Financial Instruments The Company’s financial instruments include cash and marketable securities. Due to the short-term nature of these instruments, their book value approximates their fair value. The Company’s financial instruments may include long-term debt, interest rate and cross-currency swaps, commodity derivative contracts and foreign currency derivative contracts. All derivative contracts are placed with counterparties that have an S&P, or equivalent, investment grade credit rating at the time of the contracts’ placement. At March 31, 2017 and December 31, 2016, the Company had no derivative contracts that contained credit risk related contingent features. The Company uses certain commodity derivative contracts to protect against commodity price changes related to forecasted raw material and supplies purchases. The Company primarily utilizes forward and option contracts, which are designated as cash flow hedges. At March 31, 2017 and December 31, 2016, the following commodity derivative contracts were outstanding: Commodity derivative contracts Commodity Volume hedged March 31, 2017 Volume hedged December 31, 2016 Units of measure Duration Copper 156.4 213.8 Metric Tons Dec -17 The Company manages its interest rate risk by balancing its exposure to fixed and variable rates while attempting to optimize its interest costs. The Company selectively uses interest rate swaps to reduce market value risk associated with changes in interest rates (fair value hedges). At March 31, 2017 and December 31, 2016, the Company had no outstanding interest rate swaps. The Company uses foreign currency forward and option contracts to protect against exchange rate movements for forecasted cash flows (cash flow hedges), remeasurement exposures that affect earnings (non-designated hedges), and exposures associated with the Company’s net investments in certain foreign operations (net investment hedges). Forecasted cash flows may include capital expenditures, inventory purchases, operating expenses or sales transactions designated in currencies other than the functional currency of the operating unit. The Company has also designated its Euro - denominated debt as a net investment hedge of the Company's investment in a European subsidiary. At March 31, 2017 and December 31, 2016, the following foreign currency derivative contracts were outstanding: Foreign currency derivatives (in millions) Functional currency Traded currency Notional in traded currency March 31, 2017 Notional in traded currency December 31, 2016 Duration Brazilian real Euro 2.8 — Jan - 18 Chinese renminbi US dollar 22.6 33.5 Dec - 17 Euro Chinese renminbi 93.8 — Dec - 17 Euro British pound 3.1 4.2 Dec - 17 Euro Japanese yen 1,711.2 1,004.8 Dec - 17 Euro Polish zloty 100.6 18.8 Dec - 17 Euro US dollar 30.5 35.3 Dec - 17 Japanese yen Chinese renminbi 52.1 68.7 Dec - 17 Japanese yen Korean won 4,317.1 5,689.2 Dec - 17 Japanese yen US dollar 1.5 2.0 Dec - 17 Korean won Euro 9.8 — Dec - 17 Korean won Japanese yen 649.6 539.9 Dec - 17 Korean won US dollar 17.9 14.2 Dec - 17 Mexican peso US dollar 9.6 10.5 Dec - 17 Swedish krona Euro 37.6 48.2 Dec - 17 US dollar Korean won 25,269.3 — Jun - 17 At March 31, 2017 and December 31, 2016, the following amounts were recorded in the Condensed Consolidated Balance Sheets as being payable to or receivable from counterparties under ASC Topic 815: Assets Liabilities (in millions) Location March 31, 2017 December 31, 2016 Location March 31, 2017 December 31, 2016 Foreign currency Prepayments and other current assets $ 6.2 $ 7.2 Accounts payable and accrued expenses $ 2.3 $ 1.1 Commodity Prepayments and other current assets $ 0.2 $ 0.1 Accounts payable and accrued expenses $ — $ — Effectiveness for cash flow and net investment hedges is assessed at the inception of the hedging relationship and quarterly, thereafter. To the extent that derivative instruments are deemed to be effective, gains and losses arising from these contracts are deferred into accumulated other comprehensive income (loss) ("AOCI") and reclassified into income as the underlying operating transactions are recognized. These realized gains or losses offset the hedged transaction and are recorded on the same line in the statement of operations. To the extent that derivative instruments are deemed to be ineffective, gains or losses are recognized into income. The table below shows deferred gains (losses) reported in AOCI as well as the amount expected to be reclassified to income in one year or less. The amount expected to be reclassified to income in one year or less assumes no change in the current relationship of the hedged item at March 31, 2017 market rates. (in millions) Deferred gain (loss) in AOCI at Gain (loss) expected to be reclassified to income in one year or less Contract Type March 31, 2017 December 31, 2016 Foreign currency $ 4.2 $ 5.6 $ 4.2 Commodity 0.2 (0.1 ) 0.2 Net investment hedges 22.7 29.5 — Total $ 27.1 $ 35.0 $ 4.4 Derivative instruments designated as hedging instruments as defined by ASC Topic 815 held during the period resulted in the following gains and losses recorded in income: Cash Flow Hedges Gain (loss) reclassified from AOCI to income (effective portion) Gain (loss) recognized in income (ineffective portion) (in millions) Three Months Ended Three Months Ended Contract Type Location March 31, 2017 March 31, 2016 Location March 31, 2017 March 31, 2016 Foreign currency Sales $ 1.1 $ — SG&A expense $ 0.1 $ — Foreign currency Cost of goods sold $ 0.8 $ (0.5 ) SG&A expense $ — $ 0.2 Commodity Cost of goods sold $ 0.2 $ (0.1 ) Cost of goods sold $ — $ — Fair Value Hedges (in millions) Three Months Ended March 31, 2017 Three Months Ended March 31, 2016 Contract Type Location Gain (loss) on swaps Gain (loss) on borrowings Gain (loss) on swaps Gain (loss) on borrowings Interest rate swap Interest expense and finance charges $ — $ — $ 8.7 $ (8.7 ) Derivatives not designated as hedges are used to hedge remeasurement exposures of monetary assets and liabilities designated in currencies other than the operating units’ functional currency. These derivatives resulted in the following gains and losses recorded in income: Gain (loss) recognized in income (in millions) Three Months Ended Contract Type Location March 31, 2017 March 31, 2016 Foreign currency SG&A expense $ (0.9 ) $ — |
Retirement Benefit Plans
Retirement Benefit Plans | 3 Months Ended |
Mar. 31, 2017 | |
Compensation and Retirement Disclosure [Abstract] | |
Retirement Benefit Plans | Retirement Benefit Plans The Company has a number of defined benefit pension plans and other postretirement benefit plans covering eligible salaried and hourly employees and their dependents. The estimated contributions to the Company's defined benefit pension plans for 2017 range from $15.0 million to $25.0 million , of which $3.5 million has been contributed through the first three months of the year. The other postretirement benefit plans, which provide medical and life insurance benefits, are unfunded plans. The components of net periodic benefit cost recorded in the Condensed Consolidated Statements of Operations are as follows: Pension benefits Other postretirement employee benefits (in millions) 2017 2016 Three Months Ended March 31, US Non-US US Non-US 2017 2016 Service cost $ — $ 4.3 $ — $ 4.0 $ — $ 0.1 Interest cost 2.2 2.6 2.4 3.2 0.8 1.0 Expected return on plan assets (3.3 ) (5.6 ) (3.7 ) (6.3 ) — — Amortization of unrecognized prior service credit (0.2 ) — (0.2 ) — (1.0 ) (1.2 ) Amortization of unrecognized loss 1.1 1.9 1.2 1.6 0.3 0.5 Net periodic benefit (income) cost $ (0.2 ) $ 3.2 $ (0.3 ) $ 2.5 $ 0.1 $ 0.4 |
Stock-Based Compensation
Stock-Based Compensation | 3 Months Ended |
Mar. 31, 2017 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Stock-Based Compensation | Stock-Based Compensation Under the Company's 2004 Stock Incentive Plan ("2004 Plan"), the Company granted options to purchase shares of the Company's common stock at the fair market value on the date of grant. The options vested over periods of up to three years and have a term of 10 years from date of grant. At its November 2007 meeting, the Company's Compensation Committee decided that restricted common stock awards and stock units ("restricted stock") would be awarded in place of stock options for long-term incentive award grants to employees. Restricted stock granted to employees primarily vests 50% after two years and the remainder after three years from the date of grant. Restricted stock granted to non-employee directors generally vests on the first anniversary date of the grant. In February 2014, the Company's Board of Directors replaced the expired 2004 Plan by adopting the BorgWarner Inc. 2014 Stock Incentive Plan ("2014 Plan"). On April 30, 2014, the Company's stockholders approved the 2014 Plan. Under the 2014 Plan, 8 million shares are authorized for grant, of which approximately 4.8 million shares are available for future issuance as of March 31, 2017. Stock options A summary of the Company’s stock option activity for the three months ended March 31, 2017 is as follows: Shares under option (thousands) Weighted average exercise price Weighted average remaining contractual life (in years) Aggregate intrinsic value (in millions) Outstanding and exercisable at December 31, 2016 473 $ 17.47 0.1 $ 10.4 Exercised (473 ) $ 17.47 Outstanding and exercisable at March 31, 2017 — Restricted stock The value of restricted stock is determined by the market value of the Company’s common stock at the date of grant. In the first three months of 2017, restricted stock in the amount of 776,753 shares was granted to employees. The value of the awards is recognized as compensation expense ratably over the restriction periods. As of March 31, 2017, there was $47.0 million of unrecognized compensation expense that will be recognized over a weighted average period of 2.3 years . The Company recorded restricted stock compensation expense of $6.8 million and $6.4 million for the three months ended March 31, 2017 and 2016, respectively. A summary of the Company’s nonvested restricted stock for the three months ended March 31, 2017 is as follows: Shares subject to restriction (thousands) Weighted average price Nonvested at December 31, 2016 1,429 $ 44.12 Granted 777 $ 40.07 Vested (453 ) $ 57.35 Forfeited (28 ) $ 41.87 Nonvested at March 31, 2017 1,725 $ 39.27 Total Shareholder Return Performance Share Plans The 2004 and 2014 Plans provide for awarding of performance shares to members of senior management at the end of successive three-year periods based on the Company's performance in terms of total shareholder return relative to a peer group of automotive companies. The Company recorded compensation expense of $3.1 million and $3.0 million for the three months ended March 31, 2017 and 2016, respectively. Relative Revenue Growth Performance Share Plans In the second quarter of 2016, the Company started a new performance share program to reward members of senior management based on the Company's performance in terms of revenue growth relative to the vehicle market over three-year performance periods. Total compensation expense was $3.2 million for the three months ended March 31, 2017. |
Accumulated Other Comprehensive
Accumulated Other Comprehensive Loss | 3 Months Ended |
Mar. 31, 2017 | |
Accumulated Other Comprehensive Income (Loss) [Abstract] | |
Accumulated Other Comprehensive Loss | Accumulated Other Comprehensive Loss The following tables summarize the activity within accumulated other comprehensive loss during the three months ended March 31, 2017 and 2016: (in millions) Foreign currency translation adjustments Hedge instruments Defined benefit postretirement plans Other Total Beginning balance, December 31, 2016 $ (530.3 ) $ 5.0 $ (198.1 ) $ 1.3 $ (722.1 ) Comprehensive income (loss) before reclassifications 49.0 0.5 (2.3 ) — 47.2 Income taxes associated with comprehensive income (loss) before reclassifications — (0.2 ) 1.0 — 0.8 Reclassification from accumulated other comprehensive loss — (2.1 ) 2.1 — — Income taxes reclassified into net earnings — 0.6 (0.7 ) — (0.1 ) Ending balance, March 31, 2017 $ (481.3 ) $ 3.8 $ (198.0 ) $ 1.3 $ (674.2 ) (in millions) Foreign currency translation adjustments Hedge instruments Defined benefit postretirement plans Other Total Beginning balance, December 31, 2015 $ (421.2 ) $ (2.0 ) $ (189.9 ) $ 2.9 $ (610.2 ) Comprehensive income (loss) before reclassifications 68.4 1.5 (2.1 ) (0.5 ) 67.3 Income taxes associated with comprehensive income (loss) before reclassifications — (0.4 ) 0.9 — 0.5 Reclassification from accumulated other comprehensive loss — 0.6 1.9 — 2.5 Income taxes reclassified into net earnings — — (0.9 ) — (0.9 ) Ending balance, March 31, 2016 $ (352.8 ) $ (0.3 ) $ (190.1 ) $ 2.4 $ (540.8 ) |
Contingencies
Contingencies | 3 Months Ended |
Mar. 31, 2017 | |
Commitments and Contingencies Disclosure [Abstract] | |
Contingencies | In the normal course of business, the Company is party to various commercial and legal claims, actions and complaints, including matters involving warranty claims, intellectual property claims, general liability and various other risks. It is not possible to predict with certainty whether or not the Company will ultimately be successful in any of these commercial and legal matters or, if not, what the impact might be. The Company's environmental and product liability contingencies are discussed separately below. The Company's management does not expect that an adverse outcome in any of these commercial and legal claims, actions and complaints will have a material adverse effect on the Company's results of operations, financial position or cash flows, although it could be material to the results of operations in a particular quarter. Environmental The Company and certain of its current and former direct and indirect corporate predecessors, subsidiaries and divisions have been identified by the United States Environmental Protection Agency and certain state environmental agencies and private parties as potentially responsible parties (“PRPs”) at various hazardous waste disposal sites under the Comprehensive Environmental Response, Compensation and Liability Act (“Superfund”) and equivalent state laws and, as such, may presently be liable for the cost of clean-up and other remedial activities at 27 such sites. Responsibility for clean-up and other remedial activities at a Superfund site is typically shared among PRPs based on an allocation formula. The Company believes that none of these matters, individually or in the aggregate, will have a material adverse effect on its results of operations, financial position or cash flows. Generally, this is because either the estimates of the maximum potential liability at a site are not material or the liability will be shared with other PRPs, although no assurance can be given with respect to the ultimate outcome of any such matter. Based on information available to the Company (which in most cases includes: an estimate of allocation of liability among PRPs; the probability that other PRPs, many of whom are large, solvent public companies, will fully pay the cost apportioned to them; currently available information from PRPs and/or federal or state environmental agencies concerning the scope of contamination and estimated remediation and consulting costs; and remediation alternatives), the Company has an accrual for indicated environmental liabilities of $6.1 million and $6.3 million at March 31, 2017 and at December 31, 2016, respectively. The Company expects to pay out substantially all of the amounts accrued for environmental liability over the next five years. In connection with the sale of Kuhlman Electric Corporation (“Kuhlman Electric”), a former indirect subsidiary, the Company agreed to indemnify the buyer and Kuhlman Electric against certain environmental liabilities relating to certain operations of Kuhlman Electric that pre-date the Company’s 1999 acquisition of Kuhlman Electric. Kuhlman Electric was sued by plaintiffs alleging personal injuries purportedly arising from contamination at Kuhlman Electric’s Crystal Springs, Mississippi facility. The Company understands that Kuhlman Electric was required by regulatory officials to remediate such contamination. Kuhlman Electric and its new owner tendered the personal injury lawsuits and regulatory demands to the Company. After the Company made certain payments to the plaintiffs and undertook certain remediation on Kuhlman Electric’s behalf, litigation regarding the validity of the indemnity ensued. The underlying personal injury lawsuits and indemnity litigation now have been fully resolved. The Company continues to pursue litigation against Kuhlman Electric’s historical insurers for reimbursement of amounts it paid on behalf of Kuhlman Electric under the indemnity. The Company may in the future become subject to further legal proceedings relating to these matters. Asbestos-related Liability Like many other industrial companies that have historically operated in the United States, the Company, or parties that the Company is obligated to indemnify, continues to be named as one of many defendants in asbestos-related personal injury actions. We believe that the Company’s involvement is limited because these claims generally relate to a few types of automotive products that were manufactured over thirty years ago and contained encapsulated asbestos. The nature of the fibers, the encapsulation of the asbestos, and the manner of the products’ use all lead the Company to believe that these products were and are highly unlikely to cause harm. Furthermore, the useful life of nearly all of these products expired many years ago. As of March 31, 2017 and December 31, 2016, the Company had approximately 9,500 and 9,400 pending asbestos-related claims, respectively. It is probable that additional asbestos-related claims will be asserted against the Company in the future. The Company vigorously defends against these claims, and has obtained the dismissal of the majority of the claims asserted against it without any payment. The Company likewise expects that in the vast majority of current and future asbestos-related claims in which it has been or will be named (or has an obligation to indemnify a party which has been or will be named), no payment will be made by the Company or its insurers. In the first quarter of 2017, of the approximately 500 claims resolved, 120 ( 24% ) resulted in payment being made to a claimant by or on behalf of the Company. In 2016, of the approximately 2,800 claims resolved, 352 ( 13% ) resulted in payment being made to a claimant by or on behalf of the Company. Through March 31, 2017 and December 31, 2016, the Company had accrued and paid $491.3 million and $477.7 million in indemnity (including settlement payments) and defense costs in connection with asbestos-related claims, respectively. These gross payments are before tax benefits and any insurance receipts. Indemnity and defense costs are incorporated into the Company's operating cash flows and will continue to be in the future. The Company reviews, on an ongoing basis, its own experience in handling asbestos-related claims and trends affecting asbestos-related claims in the U.S. tort system generally, for the purposes of assessing the value of pending asbestos-related claims and the number and value of those that may be asserted in the future, as well as potential recoveries from the Company’s insurers with respect to such claims and defense costs. The Company’s best estimate of the aggregate liability both for asbestos-related claims asserted but not yet resolved and potential asbestos-related claims not yet asserted, including an estimate for defense costs, is $865.7 million as of March 31, 2017. During the fourth quarter of 2016, the Company determined that a reasonable estimate of its liability for asbestos claims not yet asserted could be made, and the Company increased its aggregate estimated liability for asbestos-related claims asserted but not yet resolved and potential asbestos-related claims not yet asserted to $879.3 million as of December 31, 2016. The Company's estimate is not discounted to present value and includes an estimate of liability for potential future claims not yet asserted through December 31, 2059 with a runoff through 2067. The Company currently believes that December 31, 2067 is a reasonable assumption as to the last date on which it is likely to have resolved all asbestos-related claims, based on the nature and useful life of the Company’s products and the likelihood of incidence of asbestos-related disease in the U.S. population generally. The Company’s estimate of its aggregate liability for asbestos-related claims asserted but not yet resolved and potential asbestos-related claims not yet asserted was developed with the assistance of a third-party consultant. In developing such estimate, the third-party consultant projected a potential number of future claims based on the Company’s historical claim filings and patterns and compared that to anticipated levels of unique plaintiff asbestos-related claims asserted in the U.S. tort system against all defendants. The consultant also utilized assumptions based on the Company’s historical proportion of claims resolved without payment, historical settlement costs for those claims that result in a payment, and historical defense costs. The liabilities were then estimated by multiplying the pending and projected future claim filings by projected payments rates and average settlement amounts and then adding an estimate for defense costs. The Company’s estimate of the indemnity and defense costs for asbestos-related claims asserted but not yet resolved and potential claims not yet asserted is its best estimate of such costs. Such estimate is subject to numerous uncertainties. These include future legislative or judicial changes affecting the U.S. tort system, bankruptcy proceedings involving one or more co-defendants, the impact and timing of payments from bankruptcy trusts that presently exist and those that may exist in the future, disease emergence and associated claim filings, the impact of future settlements or significant judgments, changes in the medical condition of claimants, changes in the treatment of asbestos-related disease, and any changes in settlement or defense strategies. The balances recorded for asbestos-related claims are based on best available information and assumptions that the Company believes are reasonable, including as to the number of future claims that may be asserted, the percentage of claims that may result in a payment, the average cost to resolve such claims, and potential defense costs. Any amounts that are reasonably possible of occurring in excess of amounts recorded are believed to not be significant. The various assumptions utilized in arriving at the Company’s estimate may also change over time, and the Company’s actual liability for asbestos-related claims asserted but not yet resolved and those not yet asserted may be higher or lower than the Company’s estimate as a result of such changes. The Company has certain insurance coverage applicable to asbestos-related claims. Prior to June 2004, the settlement and defense costs associated with all asbestos-related claims were paid by the Company's primary layer insurance carriers under a series of interim funding arrangements. In June 2004, primary layer insurance carriers notified the Company of the alleged exhaustion of their policy limits. A declaratory judgment action was filed in January 2004 in the Circuit Court of Cook County, Illinois by Continental Casualty Company and related companies against the Company and certain of its historical general liability insurers. The Cook County court has issued a number of interim rulings and discovery is continuing in this proceeding. The Company is vigorously pursuing the litigation against all carriers that are parties to it, as well as pursuing settlement discussions with its carriers where appropriate. The Company has entered into settlement agreements with certain of its insurance carriers, resolving such insurance carriers’ coverage disputes through the carriers’ agreement to pay specified amounts to the Company, either immediately or over a specified period. Through March 31, 2017 and December 31, 2016, the Company had received $270.0 million in cash and notes from insurers, respectively, on account of indemnity and defense costs respecting asbestos-related claims. The Company continues to have additional excess insurance coverage available for potential future asbestos-related claims. The Company also reviews the amount of its unresolved, unexhausted excess insurance coverage for asbestos-related claims, taking into account the remaining limits of such coverage, the number and amount of claims from co-insured parties, the ongoing litigation against the Company’s insurers described above, potential remaining recoveries from insolvent insurers, the impact of previous insurance settlements, and coverage available from solvent insurers not party to the coverage litigation. Based on that review, the Company has estimated that as of March 31, 2017 and December 31, 2016 that it has $386.4 million in aggregate insurance coverage available with respect to asbestos-related claims already satisfied by the Company but not yet reimbursed by the insurers, asbestos-related claims asserted but not yet resolved, and asbestos-related claims not yet asserted, in each case together with their associated defense costs. In each case, such amounts are expected to be fully recovered. However, the resolution of the insurance coverage litigation, and the number and amount of claims on our insurance from co-insured parties, may increase or decrease the amount of such insurance coverage available to the Company as compared to the Company’s estimate. The amounts recorded in the Condensed Consolidated Balance Sheets respecting asbestos-related claims are as follows: March 31, December 31, (in millions) 2017 2016 Assets: Non-current assets $ 386.4 $ 386.4 Total insurance assets $ 386.4 $ 386.4 Liabilities: Accounts payable and accrued expenses $ 51.9 $ 51.7 Other non-current liabilities 813.8 827.6 Total accrued liabilities $ 865.7 $ 879.3 |
Restructuring
Restructuring | 3 Months Ended |
Mar. 31, 2017 | |
Restructuring and Related Activities [Abstract] | |
Restructuring | Restructuring In the fourth quarter of 2013, the Company initiated actions primarily in the Drivetrain segment designed to improve future profitability and competitiveness. As a continuation of these actions, the Company finalized severance agreements with three labor unions at separate facilities in Western Europe for approximately 450 employees. The Company recorded restructuring expense related to employee termination benefits at these facilities of $1.2 million for the three months ended March 31, 2016. In the second quarter of 2014, the Company initiated actions to improve the future profitability and competitiveness of Gustav Wahler GmbH u. Co. KG and its general partner ("Wahler"). The Company recorded restructuring expense of $1.6 million in the three ended March 31, 2016, primarily related to employee termination benefits. In the fourth quarter of 2015, the Company acquired 100% of the equity interests in Remy. As a result of actions following this transaction, the Company recorded employee termination benefits of $1.1 million in the first quarter of 2016, primarily related to contractually required severance associated with Remy executive officers. Cash payments for these restructuring activities are expected to be complete by the end of 2017. Estimates of restructuring expense are based on information available at the time such charges are recorded. Due to the inherent uncertainty involved in estimating restructuring expenses, actual amounts paid for such activities may differ from amounts initially recorded. Accordingly, the Company may record revisions of previous estimates by adjusting previously established accruals. The following tables display a rollforward of the severance accruals recorded within the Company's Condensed Consolidated Balance Sheet and the related cash flow activity for the three months ended March 31, 2017 and 2016: Severance Accruals (in millions) Drivetrain Engine Total Balance at December 31, 2016 $ 3.7 $ 2.7 $ 6.4 Cash payments (1.6 ) (2.1 ) (3.7 ) Translation adjustment — 0.1 0.1 Balance at March 31, 2017 $ 2.1 $ 0.7 $ 2.8 Severance Accruals (in millions) Drivetrain Engine Total Balance at December 31, 2015 $ 25.3 $ 4.1 $ 29.4 Provision 2.3 1.0 3.3 Cash payments (17.3 ) (2.3 ) (19.6 ) Translation adjustment 0.7 0.2 0.9 Balance at March 31, 2016 $ 11.0 $ 3.0 $ 14.0 |
Earnings Per Share
Earnings Per Share | 3 Months Ended |
Mar. 31, 2017 | |
Earnings Per Share [Abstract] | |
Earnings Per Share | Earnings Per Share The Company presents both basic and diluted earnings per share of common stock (“EPS”) amounts. Basic EPS is calculated by dividing net earnings attributable to BorgWarner Inc. by the weighted average shares of common stock outstanding during the reporting period. Diluted EPS is calculated by dividing net earnings attributable to BorgWarner Inc. by the weighted average shares of common stock and common equivalent stock outstanding during the reporting period. The dilutive impact of stock-based compensation is calculated using the treasury stock method. The treasury stock method assumes that the Company uses the assumed proceeds from the exercise of awards to repurchase common stock at the average market price during the period. The assumed proceeds under the treasury stock method include the purchase price that the grantee will pay in the future and compensation cost for future service that the Company has not yet recognized. Options are only dilutive when the average market price of the underlying common stock exceeds the exercise price of the options. The following table reconciles the numerators and denominators used to calculate basic and diluted earnings per share of common stock: Three Months Ended March 31, (in millions, except per share amounts) 2017 2016 Basic earnings per share: Net earnings attributable to BorgWarner Inc. $ 189.2 $ 164.1 Weighted average shares of common stock outstanding 211.596 217.388 Basic earnings per share of common stock $ 0.89 $ 0.75 Diluted earnings per share: Net earnings attributable to BorgWarner Inc. $ 189.2 $ 164.1 Weighted average shares of common stock outstanding 211.596 217.388 Effect of stock-based compensation 0.640 0.749 Weighted average shares of common stock outstanding including dilutive shares 212.236 218.137 Diluted earnings per share of common stock $ 0.89 $ 0.75 |
Reporting Segments
Reporting Segments | 3 Months Ended |
Mar. 31, 2017 | |
Segment Reporting [Abstract] | |
Reporting Segments | Reporting Segments The Company's business is comprised of two reporting segments: Engine and Drivetrain. These segments are strategic business groups, which are managed separately as each represents a specific grouping of related automotive components and systems. The Company allocates resources to each segment based upon the projected after-tax return on invested capital ("ROIC") of its business initiatives. ROIC is comprised of Adjusted EBIT after deducting notional taxes compared to the projected average capital investment required. Adjusted EBIT is comprised of earnings before interest, income taxes and noncontrolling interest (“EBIT") adjusted for restructuring, goodwill impairment charges, affiliates' earnings and other items not reflective of on-going operating income or loss. Adjusted EBIT is the measure of segment income or loss used by the Company. The Company believes Adjusted EBIT is most reflective of the operational profitability or loss of our reporting segments. The following tables show segment information and Adjusted EBIT for the Company's reporting segments. Net Sales by Reporting Segment Three Months Ended March 31, (in millions) 2017 2016 Engine $ 1,495.4 $ 1,399.2 Drivetrain 924.9 879.2 Inter-segment eliminations (13.3 ) (9.8 ) Net sales $ 2,407.0 $ 2,268.6 Adjusted Earnings Before Interest, Income Taxes and Noncontrolling Interest (“Adjusted EBIT”) Three Months Ended March 31, (in millions) 2017 2016 Engine $ 247.0 $ 236.7 Drivetrain 104.8 86.3 Adjusted EBIT 351.8 323.0 Lease termination settlement 5.3 — Merger and acquisition expense — 5.8 Restructuring expense — 6.4 Corporate, including equity in affiliates' earnings and stock-based compensation 44.1 37.5 Interest income (1.5 ) (1.6 ) Interest expense and finance charges 18.0 21.3 Earnings before income taxes and noncontrolling interest 285.9 253.6 Provision for income taxes 86.3 80.4 Net earnings 199.6 173.2 Net earnings attributable to the noncontrolling interest, net of tax 10.4 9.1 Net earnings attributable to BorgWarner Inc. $ 189.2 $ 164.1 Total Assets March 31, December 31, (in millions) 2017 2016 Engine $ 4,322.4 $ 4,134.6 Drivetrain 3,360.8 3,212.4 Total 7,683.2 7,347.0 Corporate * 1,400.5 1,487.7 Total assets $ 9,083.7 $ 8,834.7 ____________________________________ * Corporate assets include investments and other long-term receivables and certain deferred income taxes. |
New Accounting Pronouncements
New Accounting Pronouncements | 3 Months Ended |
Mar. 31, 2017 | |
New Accounting Pronouncements [Abstract] | |
New Accounting Pronouncements | New Accounting Pronouncements In March 2017, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2017-07, "Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost." It requires disaggregating the service cost component from the other components of net benefit cost, provides explicit guidance on how to present the service cost component and the other components of net benefit cost in the income statement and allows only the service cost component of net benefit cost to be eligible for capitalization when applicable. This guidance is effective for interim and annual periods beginning after December 15, 2017. Early adoption is permitted. The Company does not expect this guidance to have a material impact on its Consolidated Financial Statements. In January 2017, the FASB issued ASU No. 2017-04, "Simplifying the Test for Goodwill Impairment." It eliminates Step 2 from the goodwill impairment test and an entity should recognize an impairment charge for the amount by which the carrying amount of goodwill exceeds the reporting unit's fair value, not to exceed the carrying amount of goodwill. This guidance is effective for annual and any interim impairment tests in fiscal years beginning after December 15, 2019. The Company does not expect this guidance to have any impact on its Consolidated Financial Statements. In January 2017, the FASB issued Accounting Standards Update ASU No. 2017-01, "Clarifying the Definition of a Business." It revises the definition of a business and provides a framework to evaluate when an input and a substantive process are present in an acquisition to be considered a business. This guidance is effective for annual periods beginning after December 15, 2017. The Company does not expect this guidance to have any impact on its Consolidated Financial Statements. In November 2016, the FASB issued ASU No. 2016-18, "Restricted Cash." It requires that amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. This guidance is effective for interim and annual reporting periods beginning after December 15, 2017. The Company does not expect this guidance to have a material impact on its Consolidated Financial Statements. In August 2016, the FASB issued ASU No. 2016-15, "Classification of Certain Cash Receipts and Cash Payments." It provides guidance on eight specific cash flow issues with the objective of reducing the existing diversity in practice in how they are classified in the statement of cash flows. This guidance is effective for interim and annual reporting periods beginning after December 15, 2017. Early adoption is permitted, provided that all of the amendments are adopted in the same period. The Company does not expect this guidance to have a material impact on its Consolidated Financial Statements. In March 2016, the FASB issued ASU No. 2016-09, "Improvements to Employee Share-Based Payment Accounting." Under this guidance, the areas of simplification involve several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, impact on earnings per share and classification on the statement of cash flows. This guidance is effective for interim and annual reporting periods beginning after December 15, 2016. Upon adopting this guidance in the first quarter of 2017, the Company recorded a tax benefit of $0.8 million within provision for income tax related to the excess tax benefit on share-based awards and reflected the excess tax benefit in operating activities rather than financing activities in the Consolidated Statements of Cash Flows. The Company elected to apply this change in presentation prospectively and thus prior periods have not been adjusted. The Company also excluded the excess tax benefits from the assumed proceeds available to repurchase shares in the computation of diluted earnings per share for the quarter ended March 31, 2017. The impact of this change was de minimis. Additionally, the Company elected not to change its policy on accounting for forfeitures and continued to estimate the total number of awards for which the requisite service period will not be rendered. In February 2016, the FASB issued ASU No. 2016-02, "Leases (Topic 842)." Under this guidance, lessees will be required to recognize a right-of-use asset and a lease liability for all operating leases defined under previous GAAP. This guidance is effective for interim and annual reporting periods beginning after December 15, 2018. The Company is currently evaluating the impact this guidance will have on its Consolidated Financial Statements. In January 2016, the FASB issued ASU No. 2016-01, "Recognition and Measurement of Financial Assets and Financial Liabilities." It requires equity investments (except those accounted for under the equity method of accounting) to be measured at fair value with changes in fair value recognized in net income. However, an entity may choose to measure equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. It also requires separate presentation of financial assets and financial liabilities by measurement category and form of financial asset on the balance sheet or the accompanying notes to the financial statements. This guidance is effective for interim and fiscal years beginning after December 15, 2017. The Company expects to elect the measurement alternative for equity investments without readily determinable fair values and does not expect this guidance to have a material impact on its Consolidated Financial Statements. In May 2014, the FASB amended the Accounting Standards Codification to add Topic 606, "Revenue from Contracts with Customers," outlining a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and superseding most current revenue recognition guidance. This guidance is effective for interim and annual reporting periods beginning after December 15, 2017. The Company anticipates changes to the revenue recognition of pre-production activities such as customer owned tooling and engineering design & development recoveries, including the potential recording of these items as revenue. Further, the Company is currently analyzing the impact of the new guidance on its contracts and customer arrangements that include various pricing structures and cancellation clauses, which could impact the timing of revenue recognition. During 2017, based on the Company's assessment of existing contracts and revenue streams, the Company has released an internal policy to establish a framework for evaluating the impact of the new standard on the amounts and timing of revenue recognition. Further, the Company will be implementing appropriate changes to the business processes, systems and controls to support recognition and disclosure under the new standard in the third and fourth quarters of 2017 which will allow the Company to obtain the information necessary to determine the cumulative effect adjustment to be recorded upon adoption of this guidance. Training of employees on the impacts of the standard and changes to our processes, systems and controls will continue throughout 2017. The Company expects to adopt this guidance effective January 1, 2018, utilizing the Modified Retrospective approach and is currently evaluating the impact that the adoption of this guidance will have on its Consolidated Financial Statements. |
Basis of Presentation (Policies
Basis of Presentation (Policies) | 3 Months Ended |
Mar. 31, 2017 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Accounting | The accompanying unaudited Condensed Consolidated Financial Statements of BorgWarner Inc. and Consolidated Subsidiaries (the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes necessary for a comprehensive presentation of financial position, results of operations and cash flow activity required by GAAP for complete financial statements. In the opinion of management, all normal recurring adjustments necessary for a fair statement of results have been included. Operating results for the three months ended March 31, 2017 are not necessarily indicative of the results that may be expected for the year ending December 31, 2017. The balance sheet as of December 31, 2016 was derived from the audited financial statements as of that date. |
Use of Estimates | Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and accompanying notes, as well as, the amounts of revenues and expenses reported during the periods covered by those financial statements and accompanying notes. Actual results could differ from these estimates. |
Research and Development Expe25
Research and Development Expenditures (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Research and Development [Abstract] | |
Gross and net expenditures on research and development ("R&D") activities | Three Months Ended March 31, (in millions) 2017 2016 Gross R&D expenditures $ 112.0 $ 100.6 Customer reimbursements (15.6 ) (15.3 ) Net R&D expenditures $ 96.4 $ 85.3 |
Other Expense, Net (Tables)
Other Expense, Net (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Other Income and Expenses [Abstract] | |
Schedule of other expense | Three Months Ended March 31, (in millions) 2017 2016 Lease termination settlement $ 5.3 $ — Merger and acquisition expense — 5.8 Restructuring expense — 6.4 Other expense (income) 0.5 (0.5 ) Other expense, net $ 5.8 $ 11.7 |
Inventories, net (Tables)
Inventories, net (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Inventory Disclosure [Abstract] | |
Schedule of Inventory | March 31, December 31, (in millions) 2017 2016 Raw material and supplies $ 387.6 $ 378.6 Work in progress 111.9 102.9 Finished goods 171.8 174.9 FIFO inventories 671.3 656.4 LIFO reserve (14.4 ) (15.2 ) Inventories, net $ 656.9 $ 641.2 |
Property, Plant and Equipment28
Property, Plant and Equipment, net (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Property, Plant and Equipment [Abstract] | |
Disclosure of Property, Plant and Equipment | March 31, December 31, (in millions) 2017 2016 Land, land use rights and buildings $ 807.3 $ 781.6 Machinery and equipment 2,472.5 2,371.2 Capital leases 3.0 3.9 Construction in progress 366.7 338.2 Total property, plant and equipment, gross 3,649.5 3,494.9 Less: accumulated depreciation (1,236.7 ) (1,137.5 ) Property, plant and equipment, net, excluding tooling 2,412.8 2,357.4 Tooling, net of amortization 140.3 144.4 Property, plant and equipment, net $ 2,553.1 $ 2,501.8 |
Product Warranty (Tables)
Product Warranty (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Product Warranties Disclosures [Abstract] | |
Schedule of Product Warranty Liability | The following table summarizes the activity in the product warranty accrual accounts: (in millions) 2017 2016 Beginning balance, January 1 $ 95.3 $ 107.9 Provisions 27.6 24.6 Payments (15.3 ) (19.0 ) Translation adjustment 1.4 2.9 Ending balance, March 31 $ 109.0 $ 116.4 The product warranty liability is classified in the Condensed Consolidated Balance Sheets as follows: March 31, December 31, (in millions) 2017 2016 Accounts payable and accrued expenses $ 65.0 $ 63.9 Other non-current liabilities 44.0 31.4 Total product warranty liability $ 109.0 $ 95.3 |
Notes Payable and Long-Term D30
Notes Payable and Long-Term Debt (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Debt Disclosure [Abstract] | |
Schedule of Long-term Debt Instruments | March 31, December 31, (in millions) 2017 2016 Short-term debt Short-term borrowings $ 231.7 $ 156.5 Long-term debt 8.00% Senior notes due 10/01/19 ($134 million par value) 138.7 139.1 4.625% Senior notes due 09/15/20 ($250 million par value) 251.8 251.9 1.80% Senior notes due 11/7/22 (€500 million par value) 527.7 520.7 3.375% Senior notes due 03/15/25 ($500 million par value) 495.7 495.6 7.125% Senior notes due 02/15/29 ($121 million par value) 118.8 118.8 4.375% Senior notes due 03/15/45 ($500 million par value) 493.4 493.3 Term loan facilities and other 37.6 43.6 Total long-term debt 2,063.7 2,063.0 Less: current portion 23.4 19.4 Long-term debt, net of current portion $ 2,040.3 $ 2,043.6 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Fair Value Disclosures [Abstract] | |
Assets and liabilities measured at fair value | Basis of fair value measurements (in millions) Balance at March 31, 2017 Quoted prices in active markets for identical items (Level 1) Significant other observable inputs (Level 2) Significant unobservable inputs (Level 3) Valuation technique Assets: Commodity contracts $ 0.2 $ — $ 0.2 $ — A Foreign currency contracts $ 6.2 $ — $ 6.2 $ — A Other long-term receivables (insurance settlement agreement note receivable) $ 72.2 $ — $ 72.2 $ — C Liabilities: Foreign currency contracts $ 2.3 $ — $ 2.3 $ — A Basis of fair value measurements (in millions) Balance at December 31, 2016 Quoted prices in active markets for identical items (Level 1) Significant other observable inputs (Level 2) Significant unobservable inputs (Level 3) Valuation technique Assets: Commodity contracts $ 0.1 $ — $ 0.1 $ — A Foreign currency contracts $ 7.2 $ — $ 7.2 $ — A Other long-term receivables (insurance settlement agreement note receivable) $ 71.5 $ — $ 71.5 $ — C Liabilities: Foreign currency contracts $ 1.1 $ — $ 1.1 $ — A |
Financial Instruments (Tables)
Financial Instruments (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of Price Risk Derivatives | Commodity derivative contracts Commodity Volume hedged March 31, 2017 Volume hedged December 31, 2016 Units of measure Duration Copper 156.4 213.8 Metric Tons Dec -17 |
Notional Amounts of Outstanding Derivative Positions | Foreign currency derivatives (in millions) Functional currency Traded currency Notional in traded currency March 31, 2017 Notional in traded currency December 31, 2016 Duration Brazilian real Euro 2.8 — Jan - 18 Chinese renminbi US dollar 22.6 33.5 Dec - 17 Euro Chinese renminbi 93.8 — Dec - 17 Euro British pound 3.1 4.2 Dec - 17 Euro Japanese yen 1,711.2 1,004.8 Dec - 17 Euro Polish zloty 100.6 18.8 Dec - 17 Euro US dollar 30.5 35.3 Dec - 17 Japanese yen Chinese renminbi 52.1 68.7 Dec - 17 Japanese yen Korean won 4,317.1 5,689.2 Dec - 17 Japanese yen US dollar 1.5 2.0 Dec - 17 Korean won Euro 9.8 — Dec - 17 Korean won Japanese yen 649.6 539.9 Dec - 17 Korean won US dollar 17.9 14.2 Dec - 17 Mexican peso US dollar 9.6 10.5 Dec - 17 Swedish krona Euro 37.6 48.2 Dec - 17 US dollar Korean won 25,269.3 — Jun - 17 |
Derivatives Instruments in Statements of Financial Position | Assets Liabilities (in millions) Location March 31, 2017 December 31, 2016 Location March 31, 2017 December 31, 2016 Foreign currency Prepayments and other current assets $ 6.2 $ 7.2 Accounts payable and accrued expenses $ 2.3 $ 1.1 Commodity Prepayments and other current assets $ 0.2 $ 0.1 Accounts payable and accrued expenses $ — $ — |
Deferred Losses Reported In Accumulated Other Comprehensive Income Loss | (in millions) Deferred gain (loss) in AOCI at Gain (loss) expected to be reclassified to income in one year or less Contract Type March 31, 2017 December 31, 2016 Foreign currency $ 4.2 $ 5.6 $ 4.2 Commodity 0.2 (0.1 ) 0.2 Net investment hedges 22.7 29.5 — Total $ 27.1 $ 35.0 $ 4.4 |
Gain (Loss) on Derivatives Designated As Hedging Instruments | Gain (loss) reclassified from AOCI to income (effective portion) Gain (loss) recognized in income (ineffective portion) (in millions) Three Months Ended Three Months Ended Contract Type Location March 31, 2017 March 31, 2016 Location March 31, 2017 March 31, 2016 Foreign currency Sales $ 1.1 $ — SG&A expense $ 0.1 $ — Foreign currency Cost of goods sold $ 0.8 $ (0.5 ) SG&A expense $ — $ 0.2 Commodity Cost of goods sold $ 0.2 $ (0.1 ) Cost of goods sold $ — $ — Fair Value Hedges (in millions) Three Months Ended March 31, 2017 Three Months Ended March 31, 2016 Contract Type Location Gain (loss) on swaps Gain (loss) on borrowings Gain (loss) on swaps Gain (loss) on borrowings Interest rate swap Interest expense and finance charges $ — $ — $ 8.7 $ (8.7 ) Derivatives not designated as hedges are used to hedge remeasurement exposures of monetary assets and liabilities designated in currencies other than the operating units’ functional currency. These derivatives resulted in the following gains and losses recorded in income: Gain (loss) recognized in income (in millions) Three Months Ended Contract Type Location March 31, 2017 March 31, 2016 Foreign currency SG&A expense $ (0.9 ) $ — |
Retirement Benefit Plans (Table
Retirement Benefit Plans (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Compensation and Retirement Disclosure [Abstract] | |
Schedule of Net Benefit Costs | Pension benefits Other postretirement employee benefits (in millions) 2017 2016 Three Months Ended March 31, US Non-US US Non-US 2017 2016 Service cost $ — $ 4.3 $ — $ 4.0 $ — $ 0.1 Interest cost 2.2 2.6 2.4 3.2 0.8 1.0 Expected return on plan assets (3.3 ) (5.6 ) (3.7 ) (6.3 ) — — Amortization of unrecognized prior service credit (0.2 ) — (0.2 ) — (1.0 ) (1.2 ) Amortization of unrecognized loss 1.1 1.9 1.2 1.6 0.3 0.5 Net periodic benefit (income) cost $ (0.2 ) $ 3.2 $ (0.3 ) $ 2.5 $ 0.1 $ 0.4 |
Stock-Based Compensation (Table
Stock-Based Compensation (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Stock Options Activity | Shares under option (thousands) Weighted average exercise price Weighted average remaining contractual life (in years) Aggregate intrinsic value (in millions) Outstanding and exercisable at December 31, 2016 473 $ 17.47 0.1 $ 10.4 Exercised (473 ) $ 17.47 Outstanding and exercisable at March 31, 2017 — |
Nonvested Restricted Stock Activity | Shares subject to restriction (thousands) Weighted average price Nonvested at December 31, 2016 1,429 $ 44.12 Granted 777 $ 40.07 Vested (453 ) $ 57.35 Forfeited (28 ) $ 41.87 Nonvested at March 31, 2017 1,725 $ 39.27 |
Accumulated Other Comprehensi35
Accumulated Other Comprehensive Loss (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Accumulated Other Comprehensive Income (Loss) [Abstract] | |
Schedule of accumulated other comprehensive income (loss) | (in millions) Foreign currency translation adjustments Hedge instruments Defined benefit postretirement plans Other Total Beginning balance, December 31, 2016 $ (530.3 ) $ 5.0 $ (198.1 ) $ 1.3 $ (722.1 ) Comprehensive income (loss) before reclassifications 49.0 0.5 (2.3 ) — 47.2 Income taxes associated with comprehensive income (loss) before reclassifications — (0.2 ) 1.0 — 0.8 Reclassification from accumulated other comprehensive loss — (2.1 ) 2.1 — — Income taxes reclassified into net earnings — 0.6 (0.7 ) — (0.1 ) Ending balance, March 31, 2017 $ (481.3 ) $ 3.8 $ (198.0 ) $ 1.3 $ (674.2 ) (in millions) Foreign currency translation adjustments Hedge instruments Defined benefit postretirement plans Other Total Beginning balance, December 31, 2015 $ (421.2 ) $ (2.0 ) $ (189.9 ) $ 2.9 $ (610.2 ) Comprehensive income (loss) before reclassifications 68.4 1.5 (2.1 ) (0.5 ) 67.3 Income taxes associated with comprehensive income (loss) before reclassifications — (0.4 ) 0.9 — 0.5 Reclassification from accumulated other comprehensive loss — 0.6 1.9 — 2.5 Income taxes reclassified into net earnings — — (0.9 ) — (0.9 ) Ending balance, March 31, 2016 $ (352.8 ) $ (0.3 ) $ (190.1 ) $ 2.4 $ (540.8 ) |
Contingencies (Tables)
Contingencies (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Commitments and Contingencies Disclosure [Abstract] | |
Estimated future settlement of existing claims | March 31, December 31, (in millions) 2017 2016 Assets: Non-current assets $ 386.4 $ 386.4 Total insurance assets $ 386.4 $ 386.4 Liabilities: Accounts payable and accrued expenses $ 51.9 $ 51.7 Other non-current liabilities 813.8 827.6 Total accrued liabilities $ 865.7 $ 879.3 |
Restructuring (Tables)
Restructuring (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Restructuring and Related Activities [Abstract] | |
Schedule of employee related and other restructuring accruals | Severance Accruals (in millions) Drivetrain Engine Total Balance at December 31, 2016 $ 3.7 $ 2.7 $ 6.4 Cash payments (1.6 ) (2.1 ) (3.7 ) Translation adjustment — 0.1 0.1 Balance at March 31, 2017 $ 2.1 $ 0.7 $ 2.8 Severance Accruals (in millions) Drivetrain Engine Total Balance at December 31, 2015 $ 25.3 $ 4.1 $ 29.4 Provision 2.3 1.0 3.3 Cash payments (17.3 ) (2.3 ) (19.6 ) Translation adjustment 0.7 0.2 0.9 Balance at March 31, 2016 $ 11.0 $ 3.0 $ 14.0 |
Earnings Per Share (Tables)
Earnings Per Share (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Earnings Per Share [Abstract] | |
Schedule of Earnings Per Share Reconciliation | Three Months Ended March 31, (in millions, except per share amounts) 2017 2016 Basic earnings per share: Net earnings attributable to BorgWarner Inc. $ 189.2 $ 164.1 Weighted average shares of common stock outstanding 211.596 217.388 Basic earnings per share of common stock $ 0.89 $ 0.75 Diluted earnings per share: Net earnings attributable to BorgWarner Inc. $ 189.2 $ 164.1 Weighted average shares of common stock outstanding 211.596 217.388 Effect of stock-based compensation 0.640 0.749 Weighted average shares of common stock outstanding including dilutive shares 212.236 218.137 Diluted earnings per share of common stock $ 0.89 $ 0.75 |
Reporting Segments (Tables)
Reporting Segments (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Segment Reporting [Abstract] | |
Net Sales by Reporting Segment | Three Months Ended March 31, (in millions) 2017 2016 Engine $ 1,495.4 $ 1,399.2 Drivetrain 924.9 879.2 Inter-segment eliminations (13.3 ) (9.8 ) Net sales $ 2,407.0 $ 2,268.6 |
Segment Earnings Before Interest and Income Taxes | Three Months Ended March 31, (in millions) 2017 2016 Engine $ 247.0 $ 236.7 Drivetrain 104.8 86.3 Adjusted EBIT 351.8 323.0 Lease termination settlement 5.3 — Merger and acquisition expense — 5.8 Restructuring expense — 6.4 Corporate, including equity in affiliates' earnings and stock-based compensation 44.1 37.5 Interest income (1.5 ) (1.6 ) Interest expense and finance charges 18.0 21.3 Earnings before income taxes and noncontrolling interest 285.9 253.6 Provision for income taxes 86.3 80.4 Net earnings 199.6 173.2 Net earnings attributable to the noncontrolling interest, net of tax 10.4 9.1 Net earnings attributable to BorgWarner Inc. $ 189.2 $ 164.1 |
Segment assets | March 31, December 31, (in millions) 2017 2016 Engine $ 4,322.4 $ 4,134.6 Drivetrain 3,360.8 3,212.4 Total 7,683.2 7,347.0 Corporate * 1,400.5 1,487.7 Total assets $ 9,083.7 $ 8,834.7 ____________________________________ * Corporate assets include investments and other long-term receivables and certain deferred income taxes. |
Research and Development Expe40
Research and Development Expenditures (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Research and Development | ||
Gross R&D expenditures | $ 112 | $ 100.6 |
Customer reimbursements | (15.6) | (15.3) |
Net R&D expenditures | $ 96.4 | $ 85.3 |
Maximum value of R&D contract | 5.00% | 5.00% |
Other Expense, Net (Details)
Other Expense, Net (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Lease termination settlement | $ 5.3 | $ 0 |
Merger and acquisition expense | 0 | 5.8 |
Restructuring expense | 0 | 6.4 |
Other income | (0.5) | |
Other Expenses | 0.5 | |
Other expense, net | $ 5.8 | $ 11.7 |
Income Taxes (Details)
Income Taxes (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Income Tax Disclosure [Abstract] | ||
Effective income tax rate, continuing operations | 30.20% | 31.70% |
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | $ 3.4 | $ 1 |
Tax benefits related to restructuring expense | $ 1 |
Inventories, net (Details)
Inventories, net (Details) - USD ($) $ in Millions | Mar. 31, 2017 | Dec. 31, 2016 |
Inventory Disclosure [Abstract] | ||
Raw material and supplies | $ 387.6 | $ 378.6 |
Work in progress | 111.9 | 102.9 |
Finished goods | 171.8 | 174.9 |
FIFO inventories | 671.3 | 656.4 |
LIFO reserve | (14.4) | (15.2) |
Inventories, net | $ 656.9 | $ 641.2 |
Property, Plant and Equipment44
Property, Plant and Equipment, net (Details) - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | Dec. 31, 2016 | |
Property, Plant and Equipment [Line Items] | |||
Capital Expenditures Incurred but Not yet Paid | $ 62.8 | $ 85.3 | |
Capitalized interest costs | 4.3 | $ 3.7 | |
Property Plant and Equipment | |||
Total property, plant and equipment, gross | 3,649.5 | 3,494.9 | |
Less: accumulated depreciation | (1,236.7) | (1,137.5) | |
Property, plant and equipment, net, excluding tooling | 2,412.8 | 2,357.4 | |
Tooling, net of amortization | 140.3 | 144.4 | |
Property, plant and equipment, net | 2,553.1 | 2,501.8 | |
Land, land use rights and buildings [Member] | |||
Property Plant and Equipment | |||
Total property, plant and equipment, gross | 807.3 | 781.6 | |
Machinery and equipment [Member] | |||
Property Plant and Equipment | |||
Total property, plant and equipment, gross | 2,472.5 | 2,371.2 | |
Capital leases [Member] | |||
Property Plant and Equipment | |||
Total property, plant and equipment, gross | 3 | 3.9 | |
Construction in progress [Member] | |||
Property Plant and Equipment | |||
Total property, plant and equipment, gross | $ 366.7 | $ 338.2 |
Product Warranty (Details)
Product Warranty (Details) - USD ($) $ in Millions | 3 Months Ended | |||
Mar. 31, 2017 | Mar. 31, 2016 | Mar. 31, 2017 | Dec. 31, 2016 | |
Product warranty rollforward | ||||
Beginning balance, January 1 | $ 95.3 | $ 107.9 | ||
Provisions | 27.6 | 24.6 | ||
Payments | (15.3) | (19) | ||
Translation adjustment | 1.4 | 2.9 | ||
Ending balance, March 31 | 109 | 116.4 | ||
Product warranty liability | ||||
Accounts payable and accrued expenses | $ 65 | $ 63.9 | ||
Other non-current liabilities | 44 | 31.4 | ||
Total product warranty liability | $ 95.3 | $ 107.9 | $ 109 | $ 95.3 |
Minimum warranty term (in years) | 1 year | |||
Maximum warranty term (in years) | 3 years |
Notes Payable and Long-Term D46
Notes Payable and Long-Term Debt (Details) | 3 Months Ended | |||
Mar. 31, 2017USD ($) | Mar. 31, 2017EUR (€) | Dec. 31, 2016USD ($) | Jul. 20, 2016USD ($) | |
Long-term debt | ||||
Long-term Debt | $ 2,063,700,000 | $ 2,063,000,000 | ||
Current portion of long-term debt | 23,400,000 | 19,400,000 | ||
Long-term debt, net of current portion | $ 2,040,300,000 | $ 2,043,600,000 | ||
Short-term Debt, Weighted Average Interest Rate | 2.10% | 2.10% | 2.30% | |
Debt weighted average interest rate | 3.80% | 3.80% | 3.80% | |
Maximum borrowing capacity | $ 1,250,000,000 | |||
Estimated fair value of senior unsecured notes | 2,104,800,000 | $ 2,081,400,000 | ||
Fair value higher than carrying value for senior unsecured notes | 78,700,000 | 62,000,000 | ||
Letters of Credit Outstanding, Amount | 23,700,000 | 32,300,000 | ||
Short Term Borrowings [Member] | ||||
Short-term debt | ||||
Short-term borrowings | 231,700,000 | 156,500,000 | ||
8.00% Senior Notes [Member] | ||||
Long-term debt | ||||
Long-term Debt | 138,700,000 | 139,100,000 | ||
Debt instrument par value | $ 134,000,000 | |||
Debt instrument stated interest rate | 8.00% | 8.00% | ||
Debt instrument maturity date | Oct. 1, 2019 | |||
4.625% Senior Notes [Member] | ||||
Long-term debt | ||||
Long-term Debt | $ 251,800,000 | 251,900,000 | ||
Debt instrument par value | $ 250,000,000 | |||
Debt instrument stated interest rate | 4.625% | 4.625% | ||
Debt instrument maturity date | Sep. 15, 2020 | |||
1.80% Senior Notes [Member] | ||||
Long-term debt | ||||
Long-term Debt | $ 527,700,000 | 520,700,000 | ||
Debt instrument par value | € | € 500,000,000 | |||
Debt instrument stated interest rate | 1.80% | 1.80% | ||
Debt instrument maturity date | Nov. 7, 2022 | |||
3.375% Senior Notes [Member] | ||||
Long-term debt | ||||
Long-term Debt | $ 495,700,000 | 495,600,000 | ||
Debt instrument par value | $ 500,000,000 | |||
Debt instrument stated interest rate | 3.375% | 3.375% | ||
Debt instrument maturity date | Mar. 15, 2025 | |||
7.125% Senior Notes [Member] | ||||
Long-term debt | ||||
Long-term Debt | $ 118,800,000 | 118,800,000 | ||
Debt instrument par value | $ 121,000,000 | |||
Debt instrument stated interest rate | 7.125% | 7.125% | ||
Debt instrument maturity date | Feb. 15, 2029 | |||
4.375% Senior Notes [Member] | ||||
Long-term debt | ||||
Long-term Debt | $ 493,400,000 | 493,300,000 | ||
Debt instrument par value | $ 500,000,000 | |||
Debt instrument stated interest rate | 4.375% | 4.375% | ||
Debt instrument maturity date | Mar. 15, 2045 | |||
Revolving Credit Facility [Member] | ||||
Long-term debt | ||||
Current borrowing capacity | $ 1,000,000,000 | |||
Term Loan Facilities And Other [Member] | ||||
Long-term debt | ||||
Long-term Debt | 37,600,000 | 43,600,000 | ||
Interest rate swaps | ||||
Long-term debt | ||||
Derivative, Notional Amount | $ 384,000,000 | |||
Unamortized portion of interest rate swap | 8.00% Senior Notes [Member] | ||||
Long-term debt | ||||
Long-term Debt | 3,800,000 | 4,100,000 | ||
Derivative assets | 1,200,000 | 1,300,000 | ||
Unamortized portion of interest rate swap | 4.625% Senior Notes [Member] | ||||
Long-term debt | ||||
Derivative assets | 3,700,000 | 3,900,000 | ||
Commercial Paper [Member] | ||||
Short-term debt | ||||
Short-term borrowings | 160,000,000 | $ 50,800,000 | ||
Long-term debt | ||||
Current borrowing capacity | $ 1,000,000,000 |
Fair Value Measurements (Detail
Fair Value Measurements (Details) - Fair Value, Measurements, Recurring [Member] - USD ($) $ in Millions | Mar. 31, 2017 | Dec. 31, 2016 |
Market Approach Valuation Technique [Member] | ||
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Commodity Contract Asset, Noncurrent | $ 0.2 | $ 0.1 |
Assets: | ||
Foreign currency contracts | 6.2 | 7.2 |
Liabilities: | ||
Foreign currency contracts | 2.3 | 1.1 |
Market Approach Valuation Technique [Member] | Fair Value, Inputs, Level 1 [Member] | ||
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Commodity Contract Asset, Noncurrent | 0 | 0 |
Assets: | ||
Foreign currency contracts | 0 | 0 |
Liabilities: | ||
Foreign currency contracts | 0 | 0 |
Market Approach Valuation Technique [Member] | Fair Value, Inputs, Level 2 [Member] | ||
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Commodity Contract Asset, Noncurrent | 0.2 | 0.1 |
Assets: | ||
Foreign currency contracts | 6.2 | 7.2 |
Liabilities: | ||
Foreign currency contracts | 2.3 | 1.1 |
Market Approach Valuation Technique [Member] | Fair Value, Inputs, Level 3 [Member] | ||
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Commodity Contract Asset, Noncurrent | 0 | 0 |
Assets: | ||
Foreign currency contracts | 0 | 0 |
Liabilities: | ||
Foreign currency contracts | 0 | 0 |
Income Approach Valuation Technique [Member] | ||
Assets: | ||
Other long-term receivables (insurance settlement agreement note receivable) | 72.2 | 71.5 |
Income Approach Valuation Technique [Member] | Fair Value, Inputs, Level 1 [Member] | ||
Assets: | ||
Other long-term receivables (insurance settlement agreement note receivable) | 0 | 0 |
Income Approach Valuation Technique [Member] | Fair Value, Inputs, Level 2 [Member] | ||
Assets: | ||
Other long-term receivables (insurance settlement agreement note receivable) | 72.2 | 71.5 |
Income Approach Valuation Technique [Member] | Fair Value, Inputs, Level 3 [Member] | ||
Assets: | ||
Other long-term receivables (insurance settlement agreement note receivable) | $ 0 | $ 0 |
Financial Instruments - Derivat
Financial Instruments - Derivatives (Details) € in Millions, ₩ in Millions, ¥ in Millions, ¥ in Millions, £ in Millions, PLN in Millions, $ in Millions | 3 Months Ended | 12 Months Ended | |||||||||||||
Mar. 31, 2017PLNt | Dec. 31, 2016PLNt | Mar. 31, 2017USD ($) | Mar. 31, 2017JPY (¥) | Mar. 31, 2017KRW (₩) | Mar. 31, 2017CNY (¥) | Mar. 31, 2017EUR (€) | Mar. 31, 2017GBP (£) | Dec. 31, 2016USD ($) | Dec. 31, 2016JPY (¥) | Dec. 31, 2016KRW (₩) | Dec. 31, 2016CNY (¥) | Dec. 31, 2016EUR (€) | Dec. 31, 2016GBP (£) | Jul. 20, 2016USD ($) | |
Foreign currency | US dollar | Maturity June 2017 | |||||||||||||||
Derivative [Line Items] | |||||||||||||||
Notional amount of currency derivatives | ₩ | ₩ 25,269.3 | ₩ 0 | |||||||||||||
Foreign currency | Korean won | Maturity December 2017 | |||||||||||||||
Derivative [Line Items] | |||||||||||||||
Notional amount of currency derivatives | $ 17.9 | ¥ 649.6 | € 9.8 | $ 14.2 | ¥ 539.9 | € 0 | |||||||||
Foreign currency | Japanese yen | Maturity December 2017 | |||||||||||||||
Derivative [Line Items] | |||||||||||||||
Notional amount of currency derivatives | 1.5 | ₩ 4,317.1 | ¥ 52.1 | 2 | ₩ 5,689.2 | ¥ 68.7 | |||||||||
Foreign currency | Euro | Maturity December 2017 | |||||||||||||||
Derivative [Line Items] | |||||||||||||||
Notional amount of currency derivatives | PLN 100.6 | PLN 18.8 | 30.5 | ¥ 1,711.2 | ¥ 93.8 | £ 3.1 | 35.3 | ¥ 1,004.8 | ¥ 0 | £ 4.2 | |||||
Foreign currency | Chinese renminbi | Maturity December 2017 | |||||||||||||||
Derivative [Line Items] | |||||||||||||||
Notional amount of currency derivatives | 22.6 | 33.5 | |||||||||||||
Foreign currency | Swedish krona | Maturity December 2017 | |||||||||||||||
Derivative [Line Items] | |||||||||||||||
Notional amount of currency derivatives | € | 37.6 | 48.2 | |||||||||||||
Foreign currency | Brazil, Brazil Real | Maturity January 2018 | |||||||||||||||
Derivative [Line Items] | |||||||||||||||
Notional amount of currency derivatives | € | € 2.8 | € 0 | |||||||||||||
Foreign currency | Mexico, Pesos | Maturity December 2017 | |||||||||||||||
Derivative [Line Items] | |||||||||||||||
Notional amount of currency derivatives | $ 9.6 | $ 10.5 | |||||||||||||
Commodity contracts | Maturity December 2017 | |||||||||||||||
Derivative [Line Items] | |||||||||||||||
Derivative, Nonmonetary Notional Amount, Mass | t | 156.4 | 213.8 | |||||||||||||
Interest rate swaps | |||||||||||||||
Derivative [Line Items] | |||||||||||||||
Notional amount of currency derivatives | $ 384 |
Financial Instruments - Balance
Financial Instruments - Balance Sheet (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Dec. 31, 2016 | |
Derivatives, Fair Value [Line Items] | ||
Gain (loss) expected to be reclassified in one year or less | $ 4.4 | |
Accumulated other comprehensive income (loss), cumulative changes in net gain (loss) from cash flow hedges, before tax | 27.1 | $ 35 |
Foreign currency | ||
Derivatives, Fair Value [Line Items] | ||
Gain (loss) expected to be reclassified in one year or less | 4.2 | |
Accumulated other comprehensive income (loss), cumulative changes in net gain (loss) from cash flow hedges, before tax | 4.2 | 5.6 |
Foreign currency | Prepayments and other current assets | ||
Derivatives, Fair Value [Line Items] | ||
Derivative assets | 6.2 | 7.2 |
Foreign currency | Accounts payable and accrued expenses | ||
Derivatives, Fair Value [Line Items] | ||
Derivative liabilities | 2.3 | 1.1 |
Commodity contracts | ||
Derivatives, Fair Value [Line Items] | ||
Gain (loss) expected to be reclassified in one year or less | 0.2 | |
Accumulated other comprehensive income (loss), cumulative changes in net gain (loss) from cash flow hedges, before tax | 0.2 | (0.1) |
Commodity contracts | Prepayments and other current assets | ||
Derivatives, Fair Value [Line Items] | ||
Derivative assets | 0.2 | 0.1 |
Commodity contracts | Accounts payable and accrued expenses | ||
Derivatives, Fair Value [Line Items] | ||
Derivative liabilities | 0 | 0 |
Net investment hedge | ||
Derivatives, Fair Value [Line Items] | ||
Gain (loss) expected to be reclassified in one year or less | 0 | |
Accumulated other comprehensive income (loss), cumulative changes in net gain (loss) from cash flow hedges, before tax | $ 22.7 | $ 29.5 |
Financial Instruments - Income
Financial Instruments - Income Statement (Details) - USD ($) $ in Millions | 3 Months Ended | ||
Mar. 31, 2017 | Mar. 31, 2016 | Dec. 31, 2016 | |
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income, Effective Portion, Net [Abstract] | |||
Accumulated other comprehensive income (loss), cumulative changes in net gain (loss) from cash flow hedges, before tax | $ 27.1 | $ 35 | |
Gain (loss) expected to be reclassified in one year or less | 4.4 | ||
Net investment hedge | |||
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income, Effective Portion, Net [Abstract] | |||
Accumulated other comprehensive income (loss), cumulative changes in net gain (loss) from cash flow hedges, before tax | 22.7 | 29.5 | |
Gain (loss) expected to be reclassified in one year or less | 0 | ||
Commodity contracts | |||
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income, Effective Portion, Net [Abstract] | |||
Accumulated other comprehensive income (loss), cumulative changes in net gain (loss) from cash flow hedges, before tax | 0.2 | (0.1) | |
Gain (loss) expected to be reclassified in one year or less | 0.2 | ||
Commodity contracts | Cost of goods sold | |||
Derivatives Designated As Net Investment Hedges Under Topic 815 Abstract | |||
Gain (loss) reclassified from accumulated OCI into net income, effective portion, net | 0.2 | $ (0.1) | |
Foreign currency | |||
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income, Effective Portion, Net [Abstract] | |||
Accumulated other comprehensive income (loss), cumulative changes in net gain (loss) from cash flow hedges, before tax | 4.2 | $ 5.6 | |
Gain (loss) expected to be reclassified in one year or less | 4.2 | ||
Foreign currency | Sales | |||
Derivatives Designated As Net Investment Hedges Under Topic 815 Abstract | |||
Gain (loss) reclassified from accumulated OCI into net income, effective portion, net | 1.1 | ||
Foreign currency | Cost of goods sold | |||
Derivatives Designated As Net Investment Hedges Under Topic 815 Abstract | |||
Gain (loss) reclassified from accumulated OCI into net income, effective portion, net | 0.8 | (0.5) | |
Foreign currency | SG&A expense | |||
Derivatives, Fair Value [Line Items] | |||
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net | (0.9) | 0 | |
Derivatives Designated As Net Investment Hedges Under Topic 815 Abstract | |||
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net | 0.1 | 0.2 | |
Interest rate swaps | Interest expense and finance charges | |||
Derivatives, Fair Value [Line Items] | |||
Gain (Loss) on Fair Value Hedges Recognized in Earnings | 0 | 8.7 | |
Fixed rate debt swapped to floating [Member] | Interest expense and finance charges | |||
Derivatives, Fair Value [Line Items] | |||
Gain (Loss) on Fair Value Hedges Recognized in Earnings | $ 0 | $ (8.7) |
Retirement Benefit Plans (Detai
Retirement Benefit Plans (Details) - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | Dec. 31, 2017 | |
Defined Benefit Plan Disclosure [Line Items] | |||
Actual contribution to defined benefit pension plans | $ 3.5 | ||
United States Pension Plan of US Entity [Member] | |||
Components of net periodic benefit cost: | |||
Service cost | 0 | $ 0 | |
Interest cost | 2.2 | 2.4 | |
Expected return on plan assets | (3.3) | (3.7) | |
Amortization of unrecognized prior service credit | (0.2) | (0.2) | |
Amortization of unrecognized loss | 1.1 | 1.2 | |
Net periodic benefit (income) cost | (0.2) | (0.3) | |
Foreign Pension Plan [Member] | |||
Components of net periodic benefit cost: | |||
Service cost | 4.3 | 4 | |
Interest cost | 2.6 | 3.2 | |
Expected return on plan assets | (5.6) | (6.3) | |
Amortization of unrecognized prior service credit | 0 | 0 | |
Amortization of unrecognized loss | 1.9 | 1.6 | |
Net periodic benefit (income) cost | 3.2 | 2.5 | |
Other Postretirement Benefit Plan [Member] | |||
Components of net periodic benefit cost: | |||
Service cost | 0 | 0.1 | |
Interest cost | 0.8 | 1 | |
Expected return on plan assets | 0 | 0 | |
Amortization of unrecognized prior service credit | (1) | (1.2) | |
Amortization of unrecognized loss | 0.3 | 0.5 | |
Net periodic benefit (income) cost | $ 0.1 | $ 0.4 | |
Scenario, Forecast [Member] | Minimum | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Expected Contributions in Current Fiscal Year | $ 15 | ||
Scenario, Forecast [Member] | Maximum | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Expected Contributions in Current Fiscal Year | $ 25 |
Stock Based Compensation (Detai
Stock Based Compensation (Details) - USD ($) $ / shares in Units, $ in Millions | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | Dec. 31, 2016 | |
Options Roll Forward | |||
Shares outstanding under option, Beginning Balance | 473,000 | ||
Weighted average exercise price, Beginning Balance | $ 17.47 | ||
Shares outstanding under option, Exercised | (473,000) | ||
Shares outstanding under option, Exercised, Weighted average exercise price | $ 17.47 | ||
Shares outstanding under option, Ending Balance | 0 | 473,000 | |
Weighted average exercise price, Ending Balance | $ 17.47 | ||
Weighted average remaining contractual term | 1 month | ||
Aggregate intrinsic value, outstanding | $ 10.4 | ||
Status of nonvested restricted stock | |||
Nonvested shares subject to restriction, Beginning Balance | 1,429,000 | ||
Nonvested shares subject to restriction, weighted average exercise price | $ 44.12 | ||
Restricted shares granted to employees | 777,000 | ||
Granted shares subject to restriction, weighted average exercise price | $ 40.07 | ||
Shares subject to restriction, Vested | (453,000) | ||
Vested shares subject to restriction, weighted average exercise price | $ 57.35 | ||
Shares subject to restriction, Forfeited | (28,000) | ||
Forfeited shares subject to restriction, weighted average exercise price | $ 41.87 | ||
Nonvested shares subject to restriction, Ending Balance | 1,725,000 | 1,429,000 | |
Nonvested shares subject to restriction, weighted average exercise price | $ 39.27 | $ 44.12 | |
Restricted Stock [Member] | |||
Restricted stock compensation expense | |||
Restricted stock compensation expense | $ 6.8 | $ 6.4 | |
Status of nonvested restricted stock | |||
Restricted shares granted to employees | 776,753 | ||
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options | $ 47 | ||
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition | 2 years 3 months | ||
Performance Shares [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Performance share compensation expense | $ 3.1 | $ 3 | |
Relative Revenue Growth Performance Share Plans [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Performance share compensation expense | $ 3.2 | ||
Stock Incentive Plan 2004 [Member] | Stock Option [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Vesting period | 3 years | ||
Term of award | 10 years | ||
2014 Stock Incentive Plan [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Number of shares available for grant | 4,800,000 | ||
Number of shares authorized | 8,000,000 | ||
First Half Vested | Restricted Stock [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Vesting period | 2 years | ||
Percent of awards vested | 50.00% | ||
Second Half Vested | Restricted Stock [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Vesting period | 3 years |
Accumulated Other Comprehensi53
Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions | 3 Months Ended | |||
Mar. 31, 2017 | Mar. 31, 2016 | Mar. 31, 2017 | Mar. 31, 2016 | |
Foreign currency translation adjustments | ||||
Beginning Balance | $ (530.3) | $ (421.2) | ||
Comprehensive income (loss) before reclassifications | 49 | 68.4 | ||
Income taxes associated with comprehensive income (loss) before reclassifications | 0 | 0 | ||
Reclassification from accumulated other comprehensive income (loss) | 0 | 0 | ||
Income taxes reclassified into net earnings | 0 | 0 | ||
Ending Balance | (481.3) | (352.8) | ||
Hedge instruments | ||||
Beginning Balance | 5 | (2) | ||
Comprehensive income (loss) before reclassifications | 0.5 | 1.5 | ||
Income taxes associated with comprehensive income (loss) before reclassifications | (0.2) | (0.4) | ||
Reclassification from accumulated other comprehensive income (loss) | (2.1) | 0.6 | ||
Income taxes reclassified into net earnings | 0.6 | 0 | ||
Ending Balance | 3.8 | (0.3) | ||
Defined benefit postretirement plans | ||||
Beginning Balance | (198.1) | (189.9) | ||
Comprehensive income (loss) before reclassifications | (2.3) | (2.1) | ||
Income taxes associated with comprehensive income (loss) before reclassifications | 1 | 0.9 | ||
Reclassification from accumulated other comprehensive income (loss) | 2.1 | 1.9 | ||
Income taxes reclassified into net earnings | (0.7) | (0.9) | ||
Ending Balance | (198) | (190.1) | ||
Other | ||||
Beginning Balance | 1.3 | 2.9 | ||
Comprehensive income (loss) before reclassifications | 0 | (0.5) | ||
Income taxes associated with comprehensive income (loss) before reclassifications | 0 | 0 | ||
Reclassification from accumulated other comprehensive income (loss) | 0 | 0 | ||
Income taxes reclassified into net earnings | 0 | 0 | ||
Ending Balance | 1.3 | 2.4 | ||
Total | ||||
Beginning Balance | (722.1) | (610.2) | ||
Comprehensive income (loss) before reclassifications | 47.2 | 67.3 | ||
Income taxes associated with comprehensive income (loss) before reclassifications | 0.8 | 0.5 | ||
Reclassification from accumulated other comprehensive income (loss) | 0 | 2.5 | ||
Income taxes reclassified into net earnings | (0.1) | (0.9) | ||
Ending Balance | $ (722.1) | $ (610.2) | $ (674.2) | $ (540.8) |
Contingencies (Details)
Contingencies (Details) $ in Millions | 3 Months Ended | 12 Months Ended |
Mar. 31, 2017USD ($)claimsite | Dec. 31, 2016USD ($)claim | |
Accrual for environmental loss contingencies [Abstract] | ||
Waste disposal sites with potential liability under the Comprehensive Environmental Response, Compensation and Liability Act | site | 27 | |
Accrual for indicated environmental liabilities | $ 6.1 | $ 6.3 |
Timeframe most environmental liabilities will be paid out | 5 | |
Liabilities: | ||
Liability for Asbestos and Environmental Claims, Gross | $ 813.8 | $ 827.6 |
Asbestos Issue [Member] | ||
Contingencies [Abstract] | ||
Number of pending claims | claim | 9,500 | 9,400 |
Loss Contingency, Claims Settled and Dismissed, Number | claim | 500 | 2,800 |
Payment being made to a claimant by or on behalf of the company | claim | 120 | 352 |
Payment being made to a claimant by or on behalf of the company, percentage | 24.00% | 13.00% |
Company paid in defense and indemnity in advance of insurers reimbursement | $ 491.3 | $ 477.7 |
Cash and notes received from insurers | 270 | 270 |
Assets: | ||
Non-current assets | 386.4 | 386.4 |
Total insurance assets | 386.4 | 386.4 |
Liabilities: | ||
Accounts payable and accrued expenses | 51.9 | 51.7 |
Other non-current liabilities | 813.8 | 827.6 |
Total accrued liabilities | 865.7 | 879.3 |
Liability for Asbestos and Environmental Claims, Gross | $ 865.7 | $ 879.3 |
Restructuring (Details)
Restructuring (Details) $ in Millions | 3 Months Ended | ||
Mar. 31, 2017USD ($) | Mar. 31, 2016USD ($)labor_unionemployee | Nov. 10, 2015 | |
Restructuring Cost and Reserve [Line Items] | |||
Finalization of severance agreements, number of labor unions | labor_union | 3 | ||
Restructuring Reserve [Roll Forward] | |||
Provision | $ 0 | $ 6.4 | |
Employee Severance [Member] | |||
Restructuring Reserve [Roll Forward] | |||
Beginning Balance | 6.4 | 29.4 | |
Provision | 3.3 | ||
Cash payments | (3.7) | (19.6) | |
Translation adjustment | 0.1 | 0.9 | |
Ending Balance | 2.8 | 14 | |
Employee Severance [Member] | Drivetrain [Member] | |||
Restructuring Reserve [Roll Forward] | |||
Beginning Balance | 3.7 | 25.3 | |
Provision | 2.3 | ||
Cash payments | (1.6) | (17.3) | |
Translation adjustment | 0 | 0.7 | |
Ending Balance | 2.1 | 11 | |
Employee Severance [Member] | Engine [Member] | |||
Restructuring Reserve [Roll Forward] | |||
Beginning Balance | 2.7 | 4.1 | |
Provision | 1 | ||
Cash payments | (2.1) | (2.3) | |
Translation adjustment | 0.1 | 0.2 | |
Ending Balance | $ 0.7 | 3 | |
Remy International Inc. | |||
Restructuring Cost and Reserve [Line Items] | |||
Employee termination benefits | 1.1 | ||
Gustav Wahler GmbH u. Co. KG and its general partner | |||
Restructuring Reserve [Roll Forward] | |||
Provision | $ 1.6 | ||
Drivetrain [Member] | |||
Restructuring Cost and Reserve [Line Items] | |||
Employee termination costs, number of employees | employee | 450 | ||
Restructuring Reserve [Roll Forward] | |||
Provision | $ 1.2 | ||
Remy International Inc. | |||
Restructuring Cost and Reserve [Line Items] | |||
Equity interest acquired | 100.00% |
Earnings Per Share (Details)
Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Basic earnings per share: | ||
Net earnings attributable to BorgWarner Inc. | $ 189.2 | $ 164.1 |
Weighted average shares of common stock outstanding | 211,596 | 217,388 |
Basic earnings per share of common stock | $ 0.89 | $ 0.75 |
Diluted earnings per share: | ||
Net earnings attributable to BorgWarner Inc. | $ 189.2 | $ 164.1 |
Weighted average shares of common stock outstanding | 211,596 | 217,388 |
Effect of stock-based compensation | 640 | 749 |
Weighted average shares of common stock outstanding including dilutive shares | 212,236 | 218,137 |
Diluted earnings per share of common stock | $ 0.89 | $ 0.75 |
Reporting Segments (Details)
Reporting Segments (Details) $ in Millions | 3 Months Ended | |||
Mar. 31, 2017USD ($)segment | Mar. 31, 2016USD ($) | Dec. 31, 2016USD ($) | ||
Segment Reporting Information [Line Items] | ||||
Sales Revenue, Goods, Net | $ 2,407 | $ 2,268.6 | ||
Number of reportable segments | segment | 2 | |||
Adjusted earnings before interest, income taxes and noncontrolling interest | ||||
Adjusted EBIT | $ 351.8 | 323 | ||
Lease termination settlement | 5.3 | 0 | ||
Merger and acquisition expense | 0 | 5.8 | ||
Restructuring expense | 0 | 6.4 | ||
Corporate, including equity in affiliates' earnings and stock-based compensation | 44.1 | 37.5 | ||
Interest income | (1.5) | (1.6) | ||
Interest expense and finance charges | 18 | 21.3 | ||
Earnings before income taxes and noncontrolling interest | 285.9 | 253.6 | ||
Provision for income taxes | 86.3 | 80.4 | ||
Net earnings | 199.6 | 173.2 | ||
Net earnings attributable to the noncontrolling interest, net of tax | 10.4 | 9.1 | ||
Net earnings attributable to BorgWarner Inc. | 189.2 | 164.1 | ||
Segment Reporting Information - Assets | ||||
Total assets | 9,083.7 | $ 8,834.7 | ||
Operating Segments [Member] | ||||
Segment Reporting Information - Assets | ||||
Total assets | 7,683.2 | 7,347 | ||
Engine [Member] | ||||
Segment Reporting Information [Line Items] | ||||
Sales Revenue, Goods, Net | 1,495.4 | 1,399.2 | ||
Adjusted earnings before interest, income taxes and noncontrolling interest | ||||
Adjusted EBIT | 247 | 236.7 | ||
Segment Reporting Information - Assets | ||||
Total assets | 4,322.4 | 4,134.6 | ||
Drivetrain [Member] | ||||
Segment Reporting Information [Line Items] | ||||
Sales Revenue, Goods, Net | 924.9 | 879.2 | ||
Adjusted earnings before interest, income taxes and noncontrolling interest | ||||
Adjusted EBIT | 104.8 | 86.3 | ||
Segment Reporting Information - Assets | ||||
Total assets | 3,360.8 | 3,212.4 | ||
Intersegment Eliminations [Member] | ||||
Segment Reporting Information [Line Items] | ||||
Sales Revenue, Goods, Net | (13.3) | $ (9.8) | ||
Corporate, Non-Segment [Member] | ||||
Segment Reporting Information - Assets | ||||
Total assets | [1] | $ 1,400.5 | $ 1,487.7 | |
[1] | Corporate assets include investments and other long-term receivables and certain deferred income taxes. |
New Accounting Pronouncements (
New Accounting Pronouncements (Details) $ in Millions | 3 Months Ended |
Mar. 31, 2017USD ($) | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Adoption impact of excess tax benefit from share-based compensation within provision for income tax - ASU 2016 - 09 | $ 0.8 |